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Editorial 
Changes 
Leanne Tran, Editor-in-Chief 
If we look at the field of obstetrics and gynecology, the fea-
ture topic of this issue, and compare it to even ten years ago, we 
would find that in terms of the practice structure, technology and 
lifestyle, there have been significant changes. These changes are 
indicative of the way that medicine in general is progressing. As 
stated by Dr. Paul Bernstein, an obstetrician and gynecologist at 
Mount Sinai Hospital in Toronto, "I personally think that [obstet-
rics and gynecology] will evolve into more sub-specialization, 
perhaps into surgical and non-surgical aspects. It would be prac-
tical to have streaming, as that would provide focus and improve 
resources for new clinicians" . Upon reading this Profiles 
Interview, I noted that this trend is not isolated to obstetrics and 
gynecology but holds true for all of medicine. There is a notice-
able shift of medicine towards greater specialization and focus on 
individual interests whether one is a family physician, an internist 
or a surgeon. This is inevitable; as we progress through medical 
school, postgraduate training, independent practice and yes, life, 
we are exposed to different ideas and people that shape our inter-
ests. Similarly, this issue of the UWOMJ is filled with a range of 
exciting topics that include pregnancy complications, technologi-
cal developments, ethical debates, and psychosocial perspectives. 
In particular, I would like to draw your attention to an article 
written by Dr. Gideon Koren, the Ivey Chair in Molecular 
Toxicology at UWO. I encourage all of you to read this as it 
serves as an introduction to the Motherisk Program that had its 
inception at the Hospital for Sick Children in Toronto and is now 
also operating at UWO. In addition to the start of the Motherisk 
Program here at UWO, I am pleased to inform you that there have 
been major developments to UWO's Global Health curriculum 
since the publication of the last issue of the journal. The Joint 
issue editorial entitled Physicians and Peace: Promoting Peace by 
Pursuing Health spoke about a new academic discipline, "Peace 
Through Health". Research has shown that health initiatives can 
not only foster health in a region of conflict but peace as well. 
Given the increasing awareness of the importance of global 
health, it is only appropriate that the journal give an update on 
UWO's contributions to this area. I believe that the piece The 
Next Wave: Medical Education Without Borders is particularly 
timely given the recent tsunami and the changes currently under-
way in academic and clinical medicine. The article emphasizes 
the unique opportunity that we as health care workers have in 
affecting the economic, political, legal and social network around 
us and in the process, promote peace by pursuing health. Above 
all, it reminds us to take a patient-centered, culturally sensitive, 
and globally conscious approach to medicine. With this in mind, 
I hope you enjoy reading this Obstetrics and Gynecology issue as 
much as we, at the medical journal, have enjoyed putting it 
together for you. 
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Ethics 
Prenatal Testing & Disability Rights: The Role of Healthcare Professionals 
Tanya Raha, Meds 2006 
Prenatal genetic diagnosis (PND) and pre-implantation genetic diagnosis (PGD) are becoming increasingly 
avaiJable as options for parents-to-be. Despite the benefits of both procedures, several ethically troublesome 
issues remain. In particular, disability rights advocates have expressed a number of concerns: the "expres-
sivist" argument that such practices deem disabled individuals on a whole as unfit for living, that it accepts 
and encourages parental attitudes of selectivity and intolerance, that PND-related decisions are often based 
on misinformation or misconceptions, that it threatens the fair & equitable integration of disabled individu-
als as a part of our society and that it foretells a tendency towards eugenics. There is a variety of opinions on 
the use and practices of PND/PGD, both within and beyond the disabled community. As healthcare profes-
sionals who currently administer PND as a standard of care, our best response in addressing these concerns 
lies in improving " informed" consent by securing and providing good, usable, complete information about life 
with disability, especially as viewed by people who live lvith disability. It is also important to identify and work 
on our own attitudinal biases, since we come from a biomedical model where there is often a tendency to see 
disability firstly, if not exclusively, as something negative that should be ' fixed ' or 'eliminated'. Lastly, health-
care professionals are well-positioned and arguably obligated to take on an advocacy role to ensure that our 
society is one which truly does hold the attitudes, services and support for parents to freely make their repro-
ductive choice, whether that be to terminate a pregnancy or to have a potentially disabled child. 
Over the past thirty years, prenatal genetic diagnosis (PND) 
for serious medical conditions has become available and estab-
lished as the standard o care for treating pregnant women in 
Canada. PND in Canada currently includes the Maternal Serum 
Screen (MSS) and ultrasound screening tests which are offered to 
every pregnant woman, and if the woman is indicated to be at 
high risk for fetal anomaly it can include the more invasive diag-
nostic tests of amniocentesis, chorionic villus sampling (CVS) 
and further ultrasound.! ,2 More recently, with the development of 
in vitro fertilization (IVF) techniques, the practice of pre-implan-
tation genetic diagnosis (PGD) for serious medical conditions has 
also come to the forefront.3 Both PND and PGD are used to test 
for a variety of serious conditions: aneuploidy, neural tube 
defects, Cystic Fibrosis (CF), Huntington 's Disease (HD), Tay 
Sach 's disease, hemoglobinopathies and Muscular Dystrophy 
(MD) all qualify, with other possible conditions tested if such risk 
is indicated by a family history and/or carrier screening.l ,2 
PND in combination with the subsequent options to termi-
nate or carry to term a pregnancy has given us many benefits in 
increasing client knowledge at times of reproductive decision-
making, in reinforcing reproductive autonomy and choice, and in 
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preventing serious medical conditions and the costs associated 
with their treatrnent.4 Yet for all its merits, PND still leaves us 
grappling with challenging ethical and practical issues. While on 
an individual level it seems positive to inform and reinforce the 
reproductive autonomy of the parents and possibly prevent seri-
ous, debilitating medical conditions, decisions and actions such 
as these invariably (if inadvertently) have impact and convey mes-
sage at the public and political level. In particular with PND one 
of the greatest concerns has been the impact on disabled individ-
ual_s, ~enc~ we have what has been coined the "disability rights 
obJeCtiOns to PND. One prong of this argument i the expres-
s_ivist argument, which contends that PND and the selective abor-
tiOn that ~ften results to select against disabling traits express a 
hurtful attitude about, and send a hurtful message to 1 1 
. . . . . . peop e w1o 
llve wtth those same tratts.s Dtsabthty rights advocate Adri 
~sch note~, "As wit~ discrimination more generally, with p~: 
smgle tratt stands m for the whole, the trait obliterates the 
whole ... nobody finds out about the rest. The tests send th 
, . e mes-
sage that there s no need to fmd out about the rest,"5 while S 
"Th h h . axton notes, e message at t e eart of wtdespread abortiOn h 
b · f PND · h · on t e asts o ts t e greatest msult: some of us are "too flawed" in 
our very DNA to exist; we are unworthy of being born ... "5 
A second morally problematic area is the parental attitude 
argument. According to it, using prenatal tests to select against 
some traits indicates a problematic conception of and attitude 
towards parenthood. Part of the argument is that PND is rooted in 
a "fantasy and fallacy" that "parents can guarantee or create per-
fection".5 In addition, if prospective parents imagine that disabil-
ity precludes everything else that could be wonderful about the 
child, they have made biology destiny in the way that critics of the 
medical model of disability consistently resist. Good parents will 
care about raising whatever child they receive and about the rela-
tionship they will develop not about the traits the child bears. The 
"selective mentality" revea led in paying attention to particular 
traits supports a morally troubling conception of parenthood, a 
preoccupation with what is trivial and an ignorance of what is 
profound.5 
A third criticism of PND and genetic termination is that it is 
based on misinformation, and that decisions depend on a misun-
derstanding of what life with disability is like. There are many 
widely accepted beliefs about what life with disability is like for 
children with disabilities and their families . Most of these are not 
based on data . They include assumptions that people with dis-
abilities lead lives of relentless agony and frustration and that 
most marriages break up under the strain of having a child with a 
disability. Recent studies suggest, for example, that many mem-
bers of the health professions view childhood disability as pre-
dominantly negative for children and their families, in contrast to 
what research on the life satisfaction of people with disabilities 
and their families has actually shown.6,7 One study with individ-
uals with CF and HD corroborates this view, where in nearly all 
twenty-four cases (except one) respondents reported their lives in 
fairly positive terms, on many occasions expressing contentment 
or happiness with the quality of life they experienced.8 Similarly, 
three disability researchers analyzed empirical data on the impact 
of children with disabilities on families . Their review, surprising 
to many, concludes that the adaptational profiles of families that 
have a child with a disability basically resemble those of families 
that do not.9 Irrespective of whether a child is healthy or disabled, 
on average, no one family has significantly more stress or adap-
tation challenges than the other. 
Perhaps a most fundamental and irreconcilable disagreement 
over misinformation is what having a disability is "really" like for 
people: how much of the problem of disability is socially con-
structed? Nora Groce 's work establishes that much of what is dif-
ficult about having a disability stems from manifold facets of 
society, from architecture to education to aesthetic preferences. In 
choosing how to construct our societies, we "choose who will be 
disabled", and if we were to choose differently, what's disabling 
about what we now call disabilities would be largely eliminated.5 
Indeed, healthcare professionals working in PND identify the 
inability of our society to care appropriately for disabled children 
as a major problem.IO It is not unreasonable, furthermore , to have 
serious concerns that with the increasing use and accuracy of 
PND and genetic terminations, disabled individuals - already a 
minority - will become even smaller, less visible and possess less 
political clout, resulting in even less accommodation and social 
place in our society. 
Tied perhaps to our inability to create an acceptable, equi-
table place for disabled individuals within our society is a grow-
ing intolerance for 'abnormal ' individuals. Healthcare profession-
als working in PND in France cited the request for abortion in the 
case of minor anomalies such as Klinefelter or Turner syndromes, 
cleft palate, or blindness as being the most frequent ethical dilem-
ma that they were presented with, along with instances where 
diagnosis and prognosis are uncertain .IO This foretells concerns 
raised about PND progressing towards eugenics, an argument 
often dismissed as the 's lippery slope'. The French obstetricians 
and midwives commented, "The societal and medical values are 
eugenic, there is more and more eugenic thinking" .I O This high-
lights the importance of ' drawing lines in the sand' of what exact-
ly constitutes a 'sufficiently serious ' medical condition for PND 
and possible genetic termination, and yet there appears to be no 
easy way of achieving consensus on this issue among healthcare 
professionals, policy makers or the disabled community itself.' 0,5 
There is, to be sure, variation and ambivalence of opinion on 
PND amongst the disabled community and those who have had 
intimate experience with disabled individuals. For example, while 
many disability rights critics of PND may suggest that the deci-
sion to terminate is based on inaccurate perceptions or a lack of 
accurate information about what life is really like with a disabili-
ty, a qualitative study amongst women carriers of X-linked con-
ditions portrayed a different trend. The women who had grown up 
with close relatives (i.e. brothers) affected with Duchenne 's 
Muscular Dystrophy (DMD) and had first-hand experience of 
what life is like with the condition were more certain and 
unequivocal about their decision to terminate if PND indicated 
such a condition for their fetus than those women who had not 
had such intimate personal exposure to DMD. The latter women 
were less certain and at least initially more ambivalent when con-
sidering the decision to terminate.'' Furthermore, some of the 
women 'without personal experience' admitted they purposefully 
avoided finding out too much information about the condition 
they carried for fear of putting them off having children altogeth-
er, II thus indicating that more information is not always desired. 
In another study, when asked about their views on PND and 
choices, the majority of HD and CF patients indicated that PND 
and the option of termination was a positive advantage. One CF 
respondent went so far as to indicate that she would personally 
elect to terminate her child if she knew it had CF or any other ill-
nesses, "Because .. .! know what it's like. There 's no way I would 
bring a baby in this world".8 
So what should healthcare professionals do to address these 
concerns? Perhaps the answer does not lie in eliminating PND but 
by making its practice more sensitive and responsive to the objec-
tions raised. Perhaps most important, in accordance with the ethic 
of genetic counseling, is that all genetics professionals must help 
prospective parents give truly informed consent to receive testing 
and equally must help patients reach truly informed decisions 
about using test results . The first of these is by giving providers 
access to good, usable information about what disability is really 
like for children with disabilities and for their families. Education 
about life with disability - as it is viewed by people who live with 
disabilities - is still too rarely offered to those who deliver genet-
ic information. Disability must become an important topic in the 
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training of anyone who offers prenatal genetic tests, and should 
ideally be integrated into care before a prenatal screening test, 
prior to amniocentesis, and post-delivery of test results. If and 
when clients indicate that they want information about disability, 
it should be given- but what kind of information do they need? 
According to the Down Syndrome Congress, prospective parents 
who learn that their fetus has a disabling trait need to receive: 
"a) information that seeks to dispel common misconceptions 
about disability and present disability from the perspective of a 
person with a disability; b) information on community based ser-
vices for children with disabilities and their families as well as on 
financial assistance programs; c) materials on special needs adop-
tion; and d) a summary of major laws protecting the civil rights 
of persons with disabilities. People with disabilities and parents 
of people with disabilities should be available to talk with future 
parents". s 
There are PND programs that help prospective parents gath-
er information about what life is like for families with children 
who have disabilities. Yet some evidence suggests that there are 
still physicians and genetic counselors who, for example, display 
surprise or distress upon hearing that a woman wants to bring to 
term a fetus identified as having a disability. This highlights the 
importance of starting education "at home": if health profession-
als are to help individuals make truly informed decision, then 
they, like everybody else in the "majority" community, must iden-
tify and overcome biases against people with disabilities.s Rather 
than focusing on what is wrong with a disabled individual and 
what disability prevents an individual from doing, as the medical 
model often leads us to do, we need to focus on what the individ-
ual can do and on finding alternative ways for the individual to 
enjoy the same types of life experiences (if modified) that the 
"majority" do. 
If healthcare professionals truly wish to offer and support the 
widest possible range of reproductive options for their clients, 
then they also have a responsibility to advocate for and to help 
create a society where all individuals, able or ' di sabled ', are 
accommodated and welcomed. As healthcare professionals often 
have first-hand contact with disabled individuals and their fami-
lies as well as access to resources, they are well placed to be advo-
cates for their clients on the individual level. On a population 
level , they are also well positioned to be the watchdog and vocal 
advocate to ensure that social , financial , educational, medical and 
political resources for the disabled community certainly do not 
erode and continue to improve in quantity and quality. This 
includes ensuring that research on successful prevention, treat-
ment and management of various genetic conditions continues 
apace and remains a high priority, despite the conceivably easier 
path of simple eradication through PND. 
But provision of resources is not enough. We must work to 
change attitudes. For example, over the last three decades, 
tremendous progress has been made in the medical and surgical 
treatment of DS infants. Nationally in the US, a great deal of 
resources are allocated to DS infants to improve their growth and 
development. I 2 Yet the perception remains that the DS infant is 
still not openly accepted by parents and society, as illustrated by 
case reviews of parents receiving their DS infant in hospital. I 2 It 
can be argued that health professionals have the responsibility to 
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help make public attitudes more accepting of Down Syndrome. 
Professionals should encourage social and community involve-
ment of these children. National advocacy and service groups 
should be contacted periodically to promote activities to enhance 
public awareness. 
Though PND and PGD may be here to stay as the "standa_rd 
of care", the ethical issues they pose, particularly from the d~s­
ability rights standpoint, are far from resolved and cannot be ~IS­
missed. Rather, we need to listen to the concerns raised in ethical 
debate and be responsive to them so as to make PND and PGD as 
sensitive to all parties and ethically sound as possible. Now more 
then ever it is essential that we not become complacent about how 
we treat disabled members of our community. How we treat them 
is indeed a measure of the quality of our society and how we are 
willing to treat ourselves. 
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Diagnostic Review 
Ultrasound's Role in Obstetrics and Gynecology: Fetal Assessment 
and Pelvic Bleeding 
Nooreen Popat, Meds 2008, Janet Malowany, Meds 2008, and Jeremy Kelle1; Meds 2007 
Ultrasound imaging is a useful and practical screening and diagnostic tool in many areas of medicine. The 
diverse field of obstetrics and gynecology makes use of this tool in many clinical scenarios. Two will be dis-
cussed in the following article. The use of ultrasound in pregnancy provides substantial information concern-
ing fetal life and development. It is used at various stages of gestation to provide information about fetal 
growth and health. It also functions as a screening tool for congenital anomalies in fetal development. Another 
role of ultrasound is in the assessment of pelvic bleeding. It is used as an initial screening tool to provide infor-
mation about endometrial wall thickness, presence of polyps and other anatomical abnormalities. It assists in 
clinical decision making with respect to planning further diagnostic tests and future follow-up. Ultrasound is 
a highly utilized and very effective method of assessment in the field of obstetrics and gynecology. 
Ultrasound is a useful and important diagnostic tool in many 
fields of medicine. It has a great clinical utility and its impact on 
the practice of obstetrics and gynecology has been tremendous. It 
is a non-invasive and non-radioactive method of assessing and 
examining anatomy, pathology, progression of disease and fetal 
development. Since ultrasound is a non-radioactive imaging 
modality, it is of particular utility in the practice of obstetrics and 
gynecology. Radiation exposure in pregnancy must be avoided, so 
other imaging techniques such as X-ray and CT cannot be used. 
This aricle provides a brief overview of two of the common uses 
of ultrasound: prenatal assessment of fetal development and 
pelvic bleeding. 
An assessment of fetal life and pregnancy is crucial to good 
outcomes for both the mother and the baby. Ultrasound allows for 
regular and safe assessment of many important factors that con-
tribute to a healthy pregnancy and delivery. These include con-
genital anomalies, assessment of multiple gestations and assess-
ing gestational age as well as overall health of the fetus . 
In contrast, the evaluation of pelvic bleeding must be initiat-
ed quickly and assessed adequately. Ultrasound is a useful screen-
ing tool to differentiate between benign and malignant causes as 
well as guiding further diagnostic tests . 
Ultrasound has an immense role in assessment and diagnosis 
in the field of obstetrics and gynecology and the following dis-
cussion offers only a segment of its broad applications. 
PRENATAL ULTRASOUND 
Although routine ultrasound is recommended for all pregnant 
women in their second trimester1, its judicious use remains con-
troversial2,3. Many early trials provided conflicting results about 
its usefulness for pregnant women4·6, raising questions about its 
optimal timing as a screening or diagnostic tool. The value of 
ultrasound has revolutionized obstetrical care due to its ability to 
visualize the developing fetus throughout the pregnancy. 
The components of a basic ultrasound examination differ 
according to the trimester of the pregnancy. In the first trimester, 
the main goals are to confirm the presence of an intrauterine 
pregnancy and the location of the gestational sac; to identify fetal 
viability through cardiac function; to determine the presence of a 
multiple gestation and its chorionicity/arnnionicity; to assess ges-
tational age through crown-rump length; and to evaluate maternal 
pelvic organs for abnormalities including the uterus, adnexal 
structures and cul-de-sac7. For ultrasonic examinations in the sec-
ond and third trimesters, one is able to survey fetal anatomy more 
comprehensively. A basic ultrasound examination would include 
determining the fetal number, fetal presentation, documentation 
of fetal cardiac activity including heart rate, placental location, 
amniotic fluid volume, assessment of gestational age and weight 
through fetal biometry, fetal anatomical survey and an evaluation 
of maternal pelvic organs including the cervix and lower uterine 
segment?. 
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Accurate gestation dating has been a major benefit for early 
ultrasound investigations. Assessed during the first 8-12 weeks, 
the crown-rump length is the most accurate method to date gesta-
tional age throughout pregnancy, correctly determining the 
expected date of delivery within 5 days&. Between 14 and 26 
weeks, the gestational age may be approximated by combining 
the biparietal diameter, head circumference, abdominal circum-
ference , and femur length, each of which has a variation between 
7-10 days in the second trimester9, IO. Although more accurate in 
the first trimester, there is no clinically significant difference of 
gestational dating during the first two trimesters, but it is more 
variable during the third trimesterll . With more accurate gesta-
tional dating, there is a reduction in misdiagnoses of intrauterine 
growth restrictioni 2, in the use oftocolysis for inhibiting preterm 
labour 13, and in post-term labour inductionsi4, 15. 
The earlier identification of multiple births has also con-
tributed to better perinatal outcomes, and routine ultrasound is 
better able to diagnose twin pregnancies5, 15. 
The prenatal detection of congenital anomalies has been a con-
troversial benefit of ultrasonic examinations. One can identify a 
spectrum of anomalies detectable throughout different trimesters, 
with central nervous system abnormalities being the easiest to 
detect in earlier assessments. Genetic abnormalities such as aneu-
ploidy can also be easily detected early in pregnancy. Coupled with 
maternal serum screening, over 90% of trisomies 18 and 21 can be 
detected in the first trimesteri 6. The Helsinki trial demonstrated a 
significant increased detection offetal anomalies upon introduction 
of routine ultrasounds, and the significant reduction of the perina-
tal mortality rate was attributed primarily to the increase in elective 
terminations but also to the increased detection of multiple births5. 
The Eurofetus study also demonstrated increased detection of fetal 
anomalies through routine screening, primarily of central nervous 
system, urinary tract or musculoskeletal origin4. The RADIUS trial 
also discovered increased fetal anomalies upon routine screening 
but it did not uncover any improvements for perinatal outcomes 
such as mortality, preterm birth, birth weight and neonatal morbid-
ity6. These discrepancies have been attributed to the strict inclusion 
criteria for low-risk pregnancies and the lower rate of elective ter-
minations3. Yet, evidenee also suggests that even without an 
increase in abortions, increased detection of fetal anomalies result 
in better neonatal outcomes 17. 
Because 75-90% offetal anomalies occur in women considered 
to be low-risk, advantages of routine ultrasound include accurate 
gestational age, decreased labour inductions, early identification of 
multiple gestations, the detection of anatomical fetal malformations 
and fetal growth restriction and overall improved perinatal mortali-
ty ratesi 5, 19. This is the basis for the recommendation of routine 
ultrasounds for Canadian women in their second trimester' , with the 
optimal time between 16-20 weeks allowing for a more complete 
anatomical assessment?. The Society of Obstetricians and 
Gynaecologists of Canada does not recommend routine ultrasonic 
screening prior to 14 weeks unless patients present with specific 
clinical indications (Table 1)20. The American College of 
Obstetricians and Gynecologists does not mandate any routine ultra-
sound screenings, particularly if the patient is at low risk with no 
other indications for sonography, leaving the decision to both the 
physician and the patient?. 
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Table 1: Recommended guidelines for first trimester ultra-
sounds by the SOGC20 . 
I. For assessment of threatened abortion to document fetal via-
bility or for incomplete abortion to identify retained products 
of conception. . 
2. For assessment of gestational age when last menstrual penod 
date is uncertain. First trimester ultrasound is not recom-
mended to diagnose pregnancy, to date pregnancy when last 
normal menstrual period and physical examination are con-
cordant, or to investigate an inevitable abortion. 
3. Prior to pregnancy termination. 
4 . During diagnostic or therapeutic procedures requiring visual 
guidance (e.g., chorionic villus sampling, amniocentesis) and 
prior to cervical cerclage placement. 
5. For suspected multiple gestation to allow for reliable deter-
mination of chorionicity or arnnionicity. 
6. For suspected ectopic pregnancy, molar pregnancy, and sus-
pected pelvic masses. 
7. For early assessment of anatomic development in situations 
of increased risk for major fetal congenital malformations. 
8. For nuchal translucency screening when offered as part of a 
comprehensive prenatal screening and counselling program 
by experienced operators with appropriate quality assurance 
processes in place. 
ULTRASOUND FOR PELVIC BLEEDING 
Ultrasound is not just a useful tool to screen for pelvic, uter-
ine and fetal abnormalities; it is also helpful in discriminating 
between differential diagnoses for pelvic bleeding. Clinically, 
pelvic bleeding is a more common problem in postmenopausal 
women than during any other stage of female reproduction2I. 
Postmenopausal pelvic bleeding can be due to one of two broad 
categories of causes: benign and malignant. Pelvic bleeding is due 
to endometrial carcinoma in 10-20% of cases and to benign caus-
es like endometrial atrophy, polyps, and hyperplasia in the 
remaining 80-90% of ca es22. 
In cases of pelvic bleeding, transvaginal ultrasound is fre-
quently used as the initial exploratory tool to reliably examine 
both the thickness and the echostructure of the endometrium. This 
initial exploratio~ wi~l help determine if further investigation, 
such. as endome~~l bwpsy or dilatation and curettage (D&C), is 
reqUired. In addition to simple transvaginal ultrasound, saline 
infusion sonohysterography (SIS) can also be used. SIS involves 
the use of transvaginal ultrasound while the uterus is ex and d 
via insertion of small quantity of saline through a cathefer. S~S 
enhances endometrial imaging by using saline as a contrast d._ 
d . h h. me 1 urn, an It ~s a . 1gher sensitivity than transvaginal ultrasound 
alone23 . SIS IS different from simple transvaginal ultras d · 
h . h I d. . . oun m t a.t It can e p to ISti~gutsh be~een growing endometrial 
leswns, such as hyperplasta, and leswns that are stable h 
1 Lik 
. 
1 
. , sue as 
po yps. e stmp e transvagmal ultrasound, however SIS 
definitively distinguish between benign and malignan' t 1 .cann24°t 
. . eswns . 
With respect to transvagmal ultrasound examin t. f 
d . 1 h. kn a ton o en ometna t tc ~ss, any observe~ thickening or intraluminal 
masses are suggestive of hyperplasta. An endometrial th . kn 
f 4 1 l.k 1 . d " b . 1c ess o mm or ess 1 e y m Icates emgn causes of post me 
. . . nopausal 
pelvtc bleedmg such as endometrial atrophy, and so no further 
testing is done2s. Studies have shown that this is a reliable cut-off 
value with a false-negative rate as low as endometrial biopsy or 
D&C2 1• An endometrial thickness of greater than 4 mm is associ-
ated with causes such as polyps, benign hyperplasia, and carcino-
ma, with the probability of carcinoma increasing with greater 
thickness. If the endometrium is thicker than 4 mm or if it can-
' 
not be observed accurately, then SIS is used as the next explorato-
ry tool, possibly followed by endometrial biopsy or D&C. If poly-
poid lesions or focal thickenings are observed, then histological 
assessment of these tissues by endometrial biopsy is the next step. 
The combined use of transvaginal ultrasound with the 4 mm cut-
off as the first step to assess pelvic bleeding is fiscally responsi-
ble for two reasons: firstly, it decreases the total number of 
endometrial biopsies performed; secondly, it is less costly than 
performing an endometrial biopsy as the first step26. 
Concurrent examination of the echo structure of the thick-
ened endometrium or uterine mass may help to distinguish benign 
from malignant hyperplasia. More specifically, homogeneous 
thickening suggests benign hyperplasia, whereas heterogeneous 
thickening may be indicative of malignancy. Since there is no 
clear distinction between these two categories of thickening, 
cases where endometrial thickening or intraluminal masses are 
observed require further histological investigation, by either 
endometrial biopsy or D&C, in order for a definitive diagnosis to 
be made27. 
Simple transvaginal ultrasound and SIS are two useful tools 
in the assessment of postmenopausal pelvic bleeding. These tools 
can help to diagnose certain benign causes of pelvic bleeding, 
such as post menopausal endometrial atrophy. In addition, they 
can provide clear indications for more invasive assessment, such 
as endometrial biopsy or D&C, in cases where focal or diffuse 
thickenings, or polypoid lesions, are observed. Lastly, they can be 
performed at relatively low cost, compared to endometrial biopsy 
and D&C, making their use as initial exploratory tools economi-
cally conscientious. 
CONCLUSION 
Ultrasound is a commonly used tool in the clinical practice of 
obstetrics and gynecology. It is a quick, inexpensive, non-radioac-
tive imaging method of assessing anatomy, pathology and fetal 
growth. Its application in pregnancy and fetal assessment as well 
as pelvic bleeding illustrates its diverse function and applicabili-
ty in the clinical setting. Ultrasound continues to be an effective 
imaging technique in many fields of medicine and as the tech-
nology progresses indications for its use will continue to grow. 
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Profiles 
A Conversation with Dr. Paul Bernstein, Obstetrician/Gynecologist 
Betty Lee, B.Sc., Medicine 2006 
Practicing as an obstetrician/gynecologist for over 25 years, Dr. Bernstein is an exceUent role model for aspir-
ing physicians. Upon graduating from the University of Toronto's undergraduate medical prog_ram, D~. 
Bernstein first decided on a career in family medicine. However, after working for 2 years as a family physi-
cian, he discovered that his true passion was obstetrics and chose to pursue an Obstetrics and Gynecology res-
idency at the University ofToronto. In addition to being an accomplished clinician, Dr. Bernstein is also a weU-
respected teacher. 
Dr. Bernstein currently practices at Mount Sinai Hospital, one of the premier teaching facilities in Toronto. 
For seven years he also served as Residency Program Director for the University of Toronto Obstetrics and 
Gynecology program. Dr. Bernstein continues to further the education of both medical students and residents 
in his role as an Associate Professor at the University of Toronto's Faculty of Medicine. 
Why did you choose to specialize in obstetrics and gyne-
cology? 
I think it was the fascination with it all. For me, I liked the 
whole idea of obstetrics and looking after women who were hav-
ing babies. I had actually done family medicine for two years 
first , and in those days it was a little easier to switch fields , 
because we had the option of starting off in family medicine and 
then applying and specia lizing in a specific field later on. I had 
always thought about practicing in obstetrics. When I was a fam-
ily doctor, I enjoyed everything, but obstetrics was the favourite 
part of my practice so I could tell that I wanted to specia lize in it. 
I could tell that it was a career that I could do for a long time 
because there are so many interesting facets involved and I liked 
the lifestyle. I enjoy being bu y and having to juggle many task . 
Though these days, there are subspecialties in obstetrics and 
gynecology where you can have more structure and definitely the 
lifestyle is much more structured now than it used to be. 
Are you finding that the variety of subspecialties in 
obstetrics/gynecology is expanding? 
Yes, I think so. Currently there is a significant market for the 
subspecialties in obstetrics and gynecology. There is definitely 
the opportunity to become an 'expert's expert' with the volume of 
new information both in clinical practice and theoretical science. 
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When does one choose to sub-specialize and what is the 
process for doing so? 
At thi point there is no streaming in the obstetrics/gynecol-
ogy re idency program. However this is an issue that is discussed 
on a regular basis because of the thought that streaming could 
eliminate some of the residency that may not be utilized after-
ward in practice. For example, if you decide that you would like 
to focus on gynecological pelvic surgery and not on obstetrics, 
one could potentially decide to structure their residency to suit 
that and focus more of their training time on surgery and less in 
obstetrics. Streaming i an idea that is being thought about, but at 
this point, what happen is, in our program at Toronto, there is 
elective time. So for instance, if someone would like to be a sur-
gical oncologist in obs/gyn, there is a chance for that person to do 
an elective with someone in the field and get a better idea of that 
ubspecialty. There are some individuals who come into the resi-
dency knowing exactly what they want do o we try to help them 
expedite that, and expose them to the specific field that they are 
interested in. Doing research and having experience in the sub-
specialty of your choice is beneficial when applying for fe llow-
ships. 
As the former U ofT Residency Program Director what 
attributes did you look for in potential residents? ' 
Well, when I was the Residency Director, I always felt that it 
was very important to interview people and give everybody a fair 
chance to show their stuff. We rarely turned anybody away for an 
interview because we thought that that was unfair. We try to be 
fair. We evaluate everybody 's file , their letters of reference, their 
interview and people 's general impressions. Then we give them a 
score and rank the people that we really want. The interview is 
important and most of the students interview extremely well , 
because the students are bright and know how to interview. The 
interview is structured, we try to make it fair, and score it in an 
objective manner. In that way, even if different people are leading 
the interviews, the students will get similar interviews. We want 
somebody who we think is well rounded and we want people who 
have shown an interest, at some point, in the specialty. Basically, 
those are the criteria that we look for. 
Is it important to do an elective at the facility that you 
want to have your residency in? 
Well I don 't think that it is the deciding factor, but I guess it 
helps if people have seen you work. You can 't beat working in the 
field with somebody and seeing how they apply themselves. We 
think that it is very important, in the way the residency is set up, 
for people to be good team players. During residency, you really 
depend on each other. It certainly doesn 't hurt to do an elective 
there, and it might even help. Of course, it is impossible to do an 
elective everywhere, and with our program, we have had people 
from across the country. So I don 't think it really matters . 
How do you determine what percentage of your practice 
is obstetrics versus gynecology? 
Well you can choose how you structure your practice. For 
instance, I know some clinicians that don 't practice any obstet-
rics; their focus is mainly on gynecology. There are others who do 
prenatal care and not deliveries. Some doctors have a higher 
weight in their obstetrical portion and do not perform much oper-
ative gynecology but rather general gynecology. Oftentimes, 
obstetrical patients whom you treat prefer to have you follow 
them as their gynecologist. You can definitely profile your prac-
tice however you choose to suit your interests. 
Can you describe what your typical work week is like? 
In my typical week, I have about 5 or 6 half days in my office 
and I work one night on call. I spend one half day covering the 
labour floor. The rest of the week, I have time to do some surgery 
' like C-sections, and catch up on my paperwork. I like to start my 
days early. I make my rounds at 7:00 or 7:30a.m. and then I go 
into the office. I structure my lifestyle so that I don't have to work 
late. My day is usually done by 3:30- 4:00p.m. 
I also like working in a teaching facility. The benefits are that 
you have a lot of support. Many of my colleagues are sub-spe-
cialists so they are available for consulting, and residents are 
always helpful in managing your patients. 
How has the specialty changed throughout your career? 
The lifestyle is definitely not like it was in the old days. I 
think that these days, you can have your schedule be whatever you 
want it to be. There 's group coverage and in our institute, we have 
a call system so people are free if they do not want to come in and 
do deliveries a certain night. The system works. Even if you 
choose to work nights, you can structure your nights and deter-
mine your own schedule. 
In terms of the practice of obs/gyn, we have more technolo-
gy. Now there is fetal monitoring and screening tests have 
changed. Gynecological surgeries are more minimally invasive. 
How do you see the field of obstetrics and gynecology 
evolving in the future? 
I personally think that it will evolve into more sub-special-
ization, perhaps into surgical and non-surgical aspects. I think 
that with the issue of streaming, it behooves us to investigate it in 
more detail. As the body of knowledge increases, the residents 
will be responsible for learning far more techniques and informa-
tion than in the past. It would be practical to have streaming, as 
that would provide focus and improve resources for new clini-
cians. 
What's the favourite part of your career? 
I enjoy interacting with the patients. I don 't think that I could 
have ever done anything that did not involve any patient care. I 
like following my patients and seeing how they progress from day 
to day. I have patients that I've followed for a long time. I see 
them before they have their kids, I take care of them when they 
have their kids, and I see their kids grow up. It's good! 
The interesting thing is that when I get up in the morning, I 
don 't know what's going to happen to me that day! It 's so excit-
ing, it's a great mix and you get to do something that makes a big 
difference! 
Talking about 
pregnancy, before 
it happens ... 
It's your job. 
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Clinical Procedures 
The Pap Smear 
Christopher Gillis, Meds 2008 
The Pap smear is a screening test for cervical dysplasia, 
which is an early finding of possible cervical cancer. The Pap 
smear procedure is named for Dr. George Papanicolaou ( 1883-
1962) a physician from Greece. Dr. Papanicolaou first published 
his paper in 1943, along with gynecologist Dr. Herbert F. Traut, 
showing that cellular abnormalities could be detected by vaginal 
smear before a possible malignancy became invasive. The "Pap 
smear" quickly became a routine screening technique and physi-
cians were encouraged to include it during routine visits for con-
traceptive visits.' 
Human Papillomavirus (HPV) is recognized as the etiologi-
cal agent for the development of cervical dysplasia , especially 
subtypes 16 and 18 .2 After puberty and before the age of 30, ex-
ually active women have a higher chance of acquiring new HPV 
infection.' If not eliminated by the immune system, the virus can 
cause dysplasia of the cervical transformation zone. In thi region 
of the cervix, columnar ce ll are actively participating in qua-
mous cell metaplasia. It is persistent HPV infection that can cause 
progression to high grade dysplasia and cancer.' ,2 After age 30, 
detected HPV infection is most likely to be the result of a persi -
tent infection and is therefore more likely to progress.' 
The pap smear i collected using a wooden patula and a 
cytobrush. The collected specimen is then applied and fixed to a 
glass slide.3 The new tandard for Pap mears involves the u e of 
liquid-based specimen storage. The smear is performed by am-
piing the exocervix and the endocervical canal at the tran forma-
tion zone. The spatula and cytobrush are used in combination to 
sample the entire area of the transformation zone. The sample is 
then smeared onto a slide and then immediately fixed with a cyto-
logical fixative in preparation for examination by a pathologist. 
The focus of the technique is both to eliminate sampling error by 
ensuring the entire transformation zone is sampled and to elimi-
nate a drying artifact on the slides. The liquid based procedures 
are considered to be more effective by reducing the incidence of 
inadequate smears. The cells are collected in the same way as the 
conventional Pap smear, but the sampling device is placed in liq-
uid medium for the purpose of transport to the laboratory. This 
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newer liquid technique allows the cells to be plated more evenly 
upon the slide for review. Its other benefits include a reduction in 
cellular distortion, decreased debris on the slide and decreased 
contamination by red blood cells on the slide. One of the liquid 
based procedures is called the the ThinPrep Pap smear. Results of 
a study based on a comparison of the ThinPrep Pap smear and the 
conventional Pap smear shows an increased detection of low level 
cervical dysplasia (L-SIL) of 9.4% as compared to only 8% with 
the conventional Pap mear.4.5 
The current recommendation is that women should have their 
fir t Pap te t about 3 year after the onset of intercourse, or by the 
age of 21. 1 The Pap smear screening should continue every year 
for exually acti e women until there have been 3 negative Pap 
mear results, then the te ting can be performed only every 2 or 3 
year at the discretion of the physician.' ,4 The recommendations ~ 
for treatment and follow-up following abnormal Pap smear 
results are ba ed on the Bethesda system outlined at the 2001 
American Society for Colposcopy and Cervical Pathology 
on ensus Conference.6 
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Medicine and the Internet 
Telemedicine in Ontario 
Deric Morrison, Meds 2005 
Although Canada has one of the finest health care systems in the world, with state of the art medical equip-
ment, training, and care, being the second largest country in the world it is often difficult to have these ser-
vices delivered to aU the inhabitants of our nation. It is especially difficult for residents of rural areas to obtain 
access to the medical care that is characteristically delivered in larger urban centers. A recent strategy for 
delivering the advantages of large center, high technology health care to rural areas is the use of telemedicine. 
~. Specifically, the NORTH Network and the telestroke Ontario programs have recently been implemented to 
provide previously unavailable services to rural areas. This article examines the possible advantages telemed-
icine may provide rural communities, and explains how the NORTH Network and telestroke Ontario may be 
used to improve rural health care. 
The health care provided in Canada is among the best in the 
r world. We are fortunate in this country to have access to exciting 
new medical technology, excellent medical training centers and 
~ medical personnel who are held to the highest of standards. 
However, being the second largest country in the world provides 
, challenges, in that much of Canada's land is composed of rural 
area. While it is true that the majority of Canadians live in, or very 
near, urban centers that offer a full complement of medical ser-
vices, a significant proportion (-31 %) live in rural and remote 
locations that render it difficult to obtain timely medical care. 
This problem is compounded by the lack of specialized care in 
rural centers that may have access to hospitals and physicians but 
do not always have the resources or personnel to perform neces-
sary specialized medical treatment. In recognition of these chal-
lenges to our health care system, advances have been made in the 
field of telemedicine to ensure that all residents of Canada have 
timely access to the care that they require. Telemedicine has been 
defined as the use of information and communications technolo-
gy to provide health care services to individuals who are some 
distance from the health care provider. 1 Telemedicine can include 
teleradiology, telepsychiatry, telesurgery, transmission of 
echocardiographic or obstetrical ultrasound images, the telehealth 
Ontario program, or electronic referrals and consultations. These 
programs are ideal for a country such as Canada that has access 
to excellent health care but faces geographical limitations in 
delivering this care to all of its residents. 
One of the most ambitious telemedicine endeavours in this 
country has been the use of the NORTH Network telemedicine 
program in Ontario. This program began as a feasibility study in 
1995 of how telemedicine might be able to improve health care in 
northern Ontario. The NORTH Network began in earnest in 1998 
and since then has expanded to a 64-site network. The NORTH 
Network allows members of rural northern Ontario communities 
to experience consultations with medical specialists via telemed-
icine. There are more than thirty medical specialties available to 
users of the NORTH Network, including medical and surgical 
specialties and sub-specialties, anaesthesia, radiology, psychiatry, 
obstetrics, dermatology, paediatrics, physiotherapy and speech 
therapy. The technology that makes telemedicine consultations 
through the NORTH Network possible is available at 59 sites in 
rural northern Ontario; these sites can then be linked to centres 
offering specialized care such as Winnipeg, Thunder Bay, 
Sudbury, North Bay, Timmins and Sault Ste. Marie. Also, when 
necessary, consultations can be made through the NORTH 
Network to academic hospitals in southern Ontario. The technol-
ogy used by the NORTH Network is simply operated and consists 
of video screens with input from remote cameras and micro-
phones, which can be operated by a touch pad. Several medical 
devices can also be attached to the unit when needed; for exam-
ple, an otoscope may be connected to examine a patient 's ear 
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remotely. Also, radiology films and other images may be scanned 
and transmitted through the unit. Over the past few years, the 
NORTH Network has provided residents of rural northern 
Ontario a valuable option in receiving medical care. Instead of 
being required to travel long distances to see specialists - a situa-
tion that results in high cost to the individual as well as the hea lth 
care system, delays before adequate treatment can be arranged, 
and possibly even a complete lack of access to some services - it 
is now possible for these individuals to see specialists located 
hundreds of kilometres away from the proximity of their home 
comrnunity.2 More research needs to be performed to determine 
the benefit of these telemedicine services, but it seems reasonable 
that an efficiently run rural telemedicine program should provide 
many advantages to health care in much of rural Canada. 
Another example of how telemedicine can be used to 
improve patient care is the recently developed telestroke program 
in Ontario. In recent years, the treatment of acute thromboembol-
ic stroke has improved dramatically with the use of thrombolytic 
therapy such a t-PA.3 However, there are concerns regarding this 
treatment, namely that not all patients who have experienced a 
cerebrovascular event qualify for thrombolytic therapy. Only 
those who have suffered from a thromboembolic stroke would 
benefit, whereas those who have had an intracranial haemorrhage 
would likely have their condition worsened by thrombolytic ther-
apy. Also, patients who have not experienced intracranial haem-
orrhage but are at higher risk of bleeding intracranially, such as 
those with recent major surgery, bleeding diathesis, and signifi-
cant comorbidity must be excluded from thrombolytic thera-
py.3.4.5 Another major obstacle in providing patients who have had 
acute thromboembolic stroke with thrombolytic treatment is the 
short amount of time in which treatment may be administered. 
This make administering thrombolytic treatment to acute stroke 
patients in small centres almost impossible without access to a 
neurologist to confirm the appropriatene s of thrombolytic thera-
py. To this end, the telestroke program has been implemented in 
Ontario. 
The telestroke program is an initiative that give emergency 
room physicians in North Bay and Sudbury hospitals 24-hour, 
seven- day-a-week access to link with troke neurologi t at 
Toronto 's Sunnybrook and Women 's ollege Health Science 
Centre and the University Health Network. The program allow 
the neurologist to evaluate the CT image, the neurological asse -
ment and the history provided by the referring physician and to 
determine the appropriateness of thrombolytic therapy. Telestroke 
gives a significant population of patients in rural northea tern 
Ontario access to specialized services and proven effective thera-
py for acute thromboembolic stroke that would otherwise be com-
pletely unattainable. It is to be hoped that in the future this ervice 
can be expanded to provide access to the best medical treatments 
for thromboembolic stroke to all residents of rural Ontario .6 
Emerging technologies in telemedicine are an important 
aspect of the future of the health care system in Canada. Novel 
approaches to the challenges of the large geography and dispersed 
population of our country are necessary to ensure that all mem-
bers of this nation receive access to the best health care available. 
It is to be hoped that telemedicine programs such as the NORTH 
Network and Telestroke can aid in making this goal a reality. 
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Thinking on Your Feet 
An Approach to Postpartum Hemorrhage 
Jay Banerjee, Meds 2005 and Sujiva Heyn, Meds 2006 
Case: Ms. Jones is a 30 year-old female journalist, G3T2P0A0L 2 who presents to the emergency department 
in her 40th week of pregnancy in active labour. In her previous pregnancy, she sustained significant blood loss 
secondary to uterine atony and is worried about recurrence of this problem. Her current pregnancy has been 
uncomplicated, and she has experienced no blood loss, except for some minor spotting in her first trimester. 
She asks for your advice (as a clinical clerk) as to what will be done if she begins to hemorrhage? 
As a clinical clerk, the experience of witnessing an obstetri-
cal hemorrhage can be a nerve-wracking one. Postpartum hemor-
rhage is among the top five causes of maternal death worldwide 
and a major cause of maternal morbidity.' In the developing 
world, the maternal death risk is one in l 000 deliveries;2 in the 
developed world maternal morbidity is usually a result of signif-
icant blood loss. 
Postpartum hemorrhage (PPH) is classically defined as blood 
loss exceeding 500mL before completion of the third stage of 
labour.3 Signs and symptoms of hypovolemia may include faint-
ing, lethargy, tachycardia, hypotension, pallor, and diaphoresis. 
However, since a healthy pregnant woman can tolerate up to 
1 OOOmL of acute blood loss without significant hemodynamic 
disturbances, clinical determination of blood loss is often under-
estimated.4 It has been suggested that a more clinically relevant 
definition would be a drop in hematocrit of 10% or a hemorrhage 
requiring immediate transfusion.s However, acute hemorrhage is 
not reflected in hemotocrit for at least 4 hours, and full equilibra-
tion may take 24 to 48 hours.6 Complications from such an event 
include hypovolemic shock, renal failure, hepatic failure, adult 
respiratory distress syndrome, and disseminated intravascular 
coagulopathy. 7 In patients with a history of PPH, the recurrence 
risk is between 20-25%.8 
As a clinical clerk, one is often asked to take a complete his-
tory upon admission. A thorough obstetrical assessment should 
include inquiry into the various risk factors for hemorrhage. 
These include nulliparity, obesity, large size (for gestational age), 
history of prolonged third stage, antepartum hemorrhage, previ-
ous postpartum hemorrhage, and operative deliveries. The major 
causes of PPH include uterine atony, retained placental frag-
ments, placental adhesions, lower genital tract lacerations, uterine 
rupture, uterine inversion, and coagulopathies.9 If one is doing an 
obstetrical rotation in a developing country, it is important to be 
aware of the contributory factors to PPH. These include low 
socioeconomic status, anemia, infrequent prenatal checkups, and 
limited access to hospital staff and emergency resuscitative 
resources. IO,ll However, it appears that multi-parity does not 
increase the likelihood of hemorrhage.I 2 
MANAGEMENT 
As a clerk, the first step in the management of PPH is imme-
diate resuscitation, identification of the likely source, and arrest 
of bleeding. Resuscitative efforts with the aid of senior staff 
should be initiated, including monitoring vitals (heart rate, respi-
ratory rate, blood pressure, oxygen saturation), establishing two 
intravenous access sites, volume replacement (Ringer's lactate, 
Hartman's solution, or 0.9% saline), elevating the legs, cross 
matching 6 units of blood, full blood count, clotting screen, base-
line urea and electrolytes, and monitoring urine output. Evidence 
of hypovolemia is monitored with vitals and treated with crystal-
loid and blood products as required. Supplemental oxygen should 
also be given to increase oxygen delivery to microvasculature. 
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Bleeding that begins before placental delivery is often due to 
a laceration or coagulopathy, whereas bleeding that occurs after 
placental delivery suggests uterine atony, inversion, or retained 
placental fragments.13 
During the clinical clerkship year, one plays a large role after 
the baby is delivered - a role not to be underestimated. Active 
management of the third stage of labour is recommended for 
high-risk cases and is associated with reduced blood loss and a 
reduction in PPH of more than 40%.14 The principals governing 
active management include early cord clamping, prophy lactic 
uterotonic drugs before placenta l delivery, and ensuring complete 
extraction of the placenta. If a patient begins to bleed despite 
these steps, more invasive techniques are utilized . 
Active management includes bimanual compression, exami-
nation and evacuation of the placenta for retained products, and 
repair of any tears . Studies indicate that prostaglandins, which are 
endogenous uterotonic agents that he lp myometrial contractility, 
are released as a result of intrauterine pressure, myometrial 
stretching, or manipulation.15 In addi ti on, exogenous uterotonics, 
such as oxytocin, ergometrine, and IS-methyl prostaglandin 
F.2(PG-F.2) can be utili zed. However, there is an advantage of 
using PG-F.2 due to its rapid onset of action and ease of adminis-
tration . Ergometrine (0.25-0.Smg IM) and oxytocin require pro-
tection from light, refrigeration, and sterile administration .16 In 
addition, ergometrine cannot be g iven to hypertensive women. A 
recent World Health Organization study suggests the use of oxy-
tocin ( 10 IU IV/IM) as a first-line agent; however, rnisoprostol 
(600ug oral ) has also been shown to be as effective as oxytocin 
alone and a more practical option, particularly in rural settings.17, 18 
For those failing active management, uterine packing with 
gauze remains the standard of care. The Sengstaken-Blakemore 
catheter has recently emerged as a diagnostic and therapeutic tool 
via the "tamponade test". The catheter is inserted into the uterine 
cavity and inflated with normal saline to create a tamponade to 
identify women who will respond to thi s intervention; those who 
do not are prepared for laparotomy.19 Other options available 
include a Foley catheter to achieve the tamponade effect; howev-
er, its limitations include reduced leve l of inflation . In developing 
countries, with limited resources, a hydrostati c condom catheter 
is often used to control PPH quickly and effectively.20 
In the past, as a last resort , the surgica l standard of care for 
patients was a hysterectomy and ligation of internal iliac arter-
ies.21 Today, less invasive procedures are used . These include the 
B-Lynch stitch and multiple square sutures.22 With the advent of 
improved radiologica l techniques, selective a rteria l embolization 
will be an option that offers minimal complication rates and 
preservation of fertility.23 
In summary, when on the ward it is important to identify the 
risk factors for PPH when obtaining the history, and to be able to 
recognize the early signs of shock. Appropriate knowledge of med-
ical and surgical treatment modalities and the ability to counsel 
patients effectively is important in managing obstetric patients. In 
the case presented, given the patient 's history, there is a high recur-
rence risk of hemorrhage. As a c lerk, a complete history and close 
monitoring of the patient's progression through the labour and 
delivery stages are warranted, as well as active medical manage-
ment of the third stage with a uterotonic agent. If possible, delivery 
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· te medical in a tertiary care centre is suggested where the appropna . 
resources and support services will be available to manage tlus case 
effectively. A well-thought out approach to obstetric hemorrhage 
will enable one to deal with patients in a calm and rational manner. 
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Joint Replacement: Past, Present, and Future 
Sujiva Heyn, Meds 2006 and Jay Banerjee, Meds 2005 
Case: Mrs. Joint is a 55 year-old with gradual onset of a chronic, continuous, progressive non-inflammato-
ry polyarthritis, asymmetrically involving the joints of the hands, left knee, and hip, associated with a strong 
family history of osteoarthritis. She is stiff every morning for about 20 minutes, but generally worsens through 
the day and with activity. She is sometimes stiff for 1 or 2 steps after prolonged sitting. She complains of some 
pain, swelling and some loss of range of motion. On clinical exam her joints are warm, but non-erythematous. 
She is otherwise healthy, but is worried about needing hip replacement in the near future. 
Joint replacement is one of the most commonly performed 
procedures in the developed world. Total hip or knee replacement 
is usually related to osteoarthritis or some type of arthritic condi-
tion. Dr. Bourne, an orthopedic surgeon at the London Health 
Sciences Centre, reports that in Canada there are 43 ,000 hip and 
knee replacements yearly, with a 47% increase in replacements 
over the last five years. This figure is expected to double by 
2020.1 Hence, the clinical importance of hip replacement lies in 
the significant medical and social implications associated with 
the procedure. 
While joint replacement, such as hip arthroplasty, is an effec-
tive intervention strategy, the ballooning cost places a huge strain 
on the medical system. Population projections for 2041 indicate 
25% of the population will be over the age of 65 years of age, and 
it is anticipated that the demands will surpass the supply of 
resources for joint replacement.2 Hence, there is a pressing need 
to address the significant medical and social implications associ-
ated with this procedure which will continue to be a growing 
health concern among Canadians. 
PAST AND PRESENT 
The first breakthrough in this field was contributed by Sir 
John Charnley, who developed the low friction arthoplasty in the 
early 1960s.3 He experimented with stainless steel on Teflon, and 
later with high density polyethylene. Over the years, bearing sur-
faces have improved significantly. Currently, a high molecular 
weight medical grade polyethylene is used. More recently it has 
been discovered that if you can irradiate the polyethylene in an 
oxygen free environment you can get cross linking and it will 
reduce the wear by about 90%. Cross-linked polyethylene has 
resulted in increased tensile strength and longevity of parts, there-
by reducing the need for revision total hip arthroplasty.4 
CANADIAN SITUATION 
In Canada, the incident requirement rate of 2.23 total hip 
replacments per 1000 people. In 1996, the number of surgeries 
provided fell short by the 43%, while the cumulative backlog of 
people requiring surgery was about 80 000.5 At London Health 
Sciences Centre, the average waiting time from initial family 
physician consult to surgery is approximately 24 months.6 The 
significant gap between health services required and provision of 
these services demonstrates a significant inadequacy in the deliv-
ery of health care in Canada. 
The creation of the Ontario Joint Replacement Registry pro-
vides a means to improve the delivery of joint replacements in the 
province.? In this era of evidence-based medicine, the registry 
will provide a tool to monitor replacements parts, assess the effec-
tiveness of surgical procedures, and to understand patient demo-
graphics and profiles . The Western Ontario and McMaster 
University Osteoarthritis index (WOMAC) is used to assess the 
severity of disease for surgical candidates. s The registry has been 
in effect since 1995, and the data obtained will be an invaluable 
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mechanism for health policy advocates and physicians to improve 
the quality of joint replacement surgery and to address the 
increasing population demands for their care. 
COST 
At the London Health Sciences Centre, the total cost of a hip 
replacement is approximately $10,000. The distribution is as fol-
lows: prosthesis cost at $2200, five day hospital costs at $5000, 
rehabilitation therapy at $1000, physician fees at $600, anesthesia 
fees at $400, orthopedic consult at $120, and miscellaneous drug 
expenses.9 In Ontario, the entire cost is covered by OHIP. A com-
mon index to assess the outcome of a health care procedure or 
service is the cost utility measured in terms of quality-adjusted 
life year.I O, II , 12 According to Dr. Bourne, total hip and total knee 
replacements cost $5000 per quality-adjusted life year. 
Comparatively, treatment of hypertension cost $15,000 per quali-
ty-adjusted life year and a coronary-artery bypass graft cost 
$55,000 per quality-adjusted life year. Any intervention below 
$20,000 is considered cost effective, therefore hip and knee 
replacements are considered cost effective.1 3 The procedure is 
considered cost saving due to the enormous care-giver costs 
incurred by those who do not receive the intervention. In essence, 
total hip replacement virtually takes a person who is very disabled 
and restores them to normal quality of life.14 
COMPLICATIONS AND READMISSION 
The most common complications for joint replacement 
include: pulmonary embolism, deep vein thrombosis, compart-
ment syndrome, stroke, myocardial infarction, avascular necrosis, 
dislocation and infection.1 5 Due to constrained health care 
resources the lengths of post-operation stay have decreased by 
50%, while readmissions due to complications after surgery have 
increased by about 32%. 16 With a hospital stay ofthree days there 
is a 10% chance of readmission ; however, while a five or six day 
recovery period drops the rate to 2-3%. 17 Each readmission co ts 
the health care system about $1000 per day. IS While joint arthro-
plasty can be performed safely with excellent pain relief and ig-
nificantly improved functional outcome, the incidence of compli-
cations and readmission poses a health management concern . 
RECOVERY AND RANGE OF MOTION 
The recovery period ranges from 12 to 15 weeks, depending 
on the occupation of the patient.1 9 The range of motion of artifi-
cial hips is full , whereas for knees there is some decrease in range 
of motion. The increased functional capability brings about the 
greatest improvements in the patients' quality of life, along with 
improved sleep patterns and increased social interactions. The 
psychological profile of the patient is also markedly improved 
after surgical intervention.20 However, functional requirements of 
patients vary depending on cultural background, due to differ-
ences in activities of daily living.2 1 Hence, the success of joint 
replacement therapy for a patient is relative and largely deter-
mined by the individual 's expected level of function in a society. 
THE FUTURE 
The delivery of hip replacements is an area that requires sig-
nificant study and innovation. A recent international comparison 
of total hip arthroplasty cost and practice patterns indicates that 
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80% of surgeons were under pressure to reduce cost of the p_roce~ 
dure, and 68% under pressure to reduce the length of ~at~ents 
hospital stay. In this survey 30% indicated that negouatmg a 
. . ' . h t important 
reduced tmplant pnce from the supplter was t e mos 
cost-cutting measure as the variability of cost can be as much ~s 
' · · rth paedtc 700% for an implant.22 In other words, mfluencmg o 0 
. fi rea of health care surgeon's practice pattern should be a ocus a 
policy-makers. 
1 Another possible strategy is to regionalize hip arthrop asty to 
an outpatient procedure. The apparent advantages of such a strat-
egy are shorter lengths of stay, ability to perform -~crea_sed num-
ber of procedures, decreased costs and shorter wa1tmg-t1me~. ~he 
possible drawbacks of such a strategy are increased rea?misswn 
rates due to complications and increased use of cor:nm~Jmty-based 
services. Studies in Alberta indicate that regwnahzatwn has had 
minimal impact on death and readmission rates, making this a 
plausible strategy.23 
Also, primary care education to recognize congenital hip 
dysplasia is an equally important prevention strategy. At the 
London Health Sciences Centre, approximately 75% of hip 
replacements are related to dysplastic hip conditions.24 The con-
tribution of a family physician in recognizing and appropriately 
treating these conditions in infants would thereby alleviate the 
demands on the health care system through a cost-effective and 
efficient early intervention strategy. 
The future of hip replacement surgery is indeed a promising 
one. In addition to the technological advances discussed previ-
ously, with the advent of minimally invasive or SMART instru-
ments the urgical precision of the procedure is markedly improv-
ing which will lead to fewer complications and shorter recovery 
times once uch in truments become commonplace in the surgi-
cal field .25 In addition, on-going laboratory studies on the regen-
eration of cartilage surfaces may one day result in eliminating the 
need for the procedure entirely.26 
While the medical advances will alleviate some of the 
demand for the joint replacement the resource management 
issue hall determine the quality and quantity of care available to 
patient . Hence it is necessary for future physicians to be aware 
of the multi-factorial aspects of health care in order to effectively 
erve the growing demands of the Canadian population. 
REFERENCES 
i . Bourne R. Divi ion of Orthopedics, London Health Sciences Centre, 
University of Western Ontario, interview. 2003 Feb i i 
2. Papadimitropoulos EA. Coyle. PC. Josse RG. Greenwood CE. Current 
and projected rates of hip fra cture in Canada. CMAJ i997; 157:1357-
63. 
3. ibid. (i ) 
4. McKellop H. , Shen FW. Lu B .. Campbell P. Salovey R. Development of 
an extremely wear-resistant ultra high molecular IVeight polyethylene 
for total hip replacements. J Orthop Res i999 Mar: i 7(2) : i 57-67. 
5. Hunter D. Robertson D. Total hip replacement: need far exceeds supply. 
CMAJ. 200i ; i65(4) : 395 
6. Ibid. (1) 
7. Bourne RB, Sibbald WJ. Doig G, Lee L. Adolph S. Robertson D 
Provencher M. The Southwestern Ontario Joint Replacement Pi/ ' 
Proj ect: electronic point-of-care data collection. Southwestern On tar~~ 
Study Group. Can J Surg. 200i Jun;44(3) :i99-202. 
8. Jinks C, Jordan K, Croft P Measuring the population impact of knee 
pain and disability with the Western Ontario and McMaster Universities 
Osteoarthritis Index (WOMAC) . Pain. 2002 Nov; JOO(l-2):55-64. 
9. Ibid. (!) 
10. O'Shea K, Bale E, Murray P Cost analysis of primary total hip replace-
ment. lr Med J 2002 Jun; 95(6) : 177-80. 
11. Givan U. Ginsberg GM, Horoszowski H, Shemer J Cost-utility analysis 
of total hip arthroplasties. ln t J Techno/ As ess Health Care. 1998 
Fall; 14(4): 735 42. 
12. Torran ce GW. Feeny D. Utilities and quality-adjusted life years. 1nt J 
Techno/ Assess Health Care 1989; 5(4) : 559-75. 
13. Ibid. (1) 
14. Jones CA. Voaklander DC, Johnston DW. Suarez Almazor ME. Health 
related quality of life outcomes after total hip and knee arthroplasties in 
a community based population. J Rheumatol. 2000 Ju/;2 7(7): 1745-52. 
15. Saleh KJ. Kassim R. Yoon P. Vorlicl..y LN Complications of total hip 
arthroplasty. Am J Orthop. 2002 Aug;31 (8):485-8. 
16. Alibhai A, Saunders D, Johnston DW. Bay K. Total Hip and Knee 
replacement surgeries in Alberta utili::ation and associated outcomes. 
Health Manage Forum 2001 Summer; 14(2): 25-32. 
17. Ibid. (J) 
18. Ibid. (1) 
19. Ibid. (1) 
20. Knutsson S. Engberg !B. An evaluation of patients' quality of life before, 
6 weeks and 6 months after total hip replacement surgery. J Adv Nurs. 
1999 Dec;30(6): 1349-59. 
21. Mull holland SJ Wyss UP Activities of Daily living in non- Western cul-
tures: range of motion requirements fo r hip and /,:-nee joint implants. Inti 
J Rehab Res 2001; 24: 191-198 
22. Met:: CM, Freiberg AA. An international comparative study of total hip 
arthroplasty and practice patterns. J Arthroplasty, 1998 Apr; 13(3):296-
8 
23. Hamilton SM. Johnston WC, Voaklander DC. Outcomes after the 
regionalization of major surgical procedures in the Alberta Capital 
Health Region. Can J Surg, 2001 Feb; 44(1):51-8. 
24. Ibid. (1) 
25. Specht LM. Koval KJ. Robotics and computer-assisted orthopaedic 
surgery1. 
26. Bull Hasp Jt Dis. 2001-2002;60(3-4): 168-72. 
2 7. Ringe J, Kaps C. Burmester GR. Sittinger M. Stem cells for regenerative 
medicin e: advances in the engineering of tissues and organs. 
Naturwissenschaften. 2002 Aug;89(8):338-51 . 
Breakth 
M ore than medicine, it's a way of thinking. 
As Canadians, we 're often defined by our approach. to healthcare . 
And at AstraZeneca, we 're proud to play a leading role in 
furthering a system which can guarantee all patients, pharmacists 
a nd doctors from coast to coast timely access to the most 
innovative and effective treatments available . 
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breakthroughs in the way we as Canadians think about healthcare. 
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Zebra Files 
Amniotic Fluid Embolism- An Unpredictable and Often Catastrophic 
Obstetrical Emergency 
Stephen Chihrin, Meds 2008 and Leslie Wong, Meds 2007 
Amniotic fluid embolism (AFE) is a rare and unpredictable obstetrical emergency, occurring in less than 1 in 
20,000 births. It is of considerable importance given that mortality rates exceed 60% for mothers and 20% 
for newborns. Symptoms begin with acute dyspnea and shock and frequently progress to cardiac arrest with-
in minutes. Significant uterine hemorrhage, neurological sequelae, and fetal bradycardia often follow in 
patients who survive the initial cardiorespiratory events. Two models for the pathogenesis of AFE have been 
proposed and are detailed in this report along with basic principles of diagnosis and management. 
Amniotic fluid emboli m (AFE) is a rare and deadly labor 
event in which amniotic fluid gains entry into maternal circula-
tion rapidly leading to severe respiratory, cardiovascular, and neu-
rologic complications' . This condition was first documented in 
19261 ; however, medical-historical accounts of the unexpected 
death of Princess Charlotte of Wales in 1817, and the public out-
cry leading to her obstetrician 's ultimate suicide, suggests that 
AFE was observed much earlier2. 
Amniotic fluid embolism has been estimated to occur in 1 in 
20,000 pregnancies3. As of yet, no preventive strategies have been 
developed for AFE, nor can it be predicted. Compounding this 
challenge, maternal and fetal mortality rates of over 60% and 
20% respectively are regularly reported4 . In patients who survive, 
neurological sequelae have been reported as high as 85%4-6. 
It should also be noted that AFE has been observed during 
ruptured membranes and caesarian section, though insufficient 
data exists to estimate incidence or predisposing factors?. 
PATHOPHYSIOLOGY 
AFE occurs when amniotic fluid gains entry into maternal 
circulation . The current belief is that whi le fluid exchange does 
not necessarily lead to AFE, AFE is more likely to develop if the 
delivery has led to a greater-than-normal pressure gradient 
between the amniotic fluid and maternal circulations. Other 
researchers have suggested that certain maternal factors and/or 
factors in the anmiotic fluid may influence the onset of AFE'. 
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While the pecific pathophysiological events have not been 
c learly identified, the traditional pathway is as fo llows9: 
Amniotic fluid enters maternal circulation and reaches pul-
monary circulation through the pulmonary artery. Right-to-
left shunting is evident, as emboli are frequently found in 
coronary va culature a well. 
Leukotrienes, surfactant, thromboxane A2 , endothelin, 
vernix, fetal hair, and mucin act upon the vasculature of the 
lungs, leading to negative inotropism, capillary leak, and ulti-
mately bronchospa m. 
Pulmonary congestion en ues, leading to right heart failure , 
decrea ed cardiac output, as well as hypotension. 
Disseminated intravascular coagulopathy may also occur 
secondary to ~he effects of fetal thromboplastins, leading to 
profus~ bleedmg from the uterus and any iatrogenic entry 
pomts mto maternal vasculature. 
Systemic _ hypotension in the mother quickly leads to a 
decrease m utenne and placental perfusion, which in tur 
. . 'f ' . n~n 
tngger s1gm tcant cardiOvascular complications in th c tu 
A h 
e 1e s. 
more recent t eory suggests that AFE may be · 
. . trnmune-
med tatedtO. In thts model, the maternal immune system 
. . mounts a 
response to feta l antigens released mto the maternal intr 1 . . avascu ar 
pace, as evidenced by mcreased levels of serum trypta Th . 
d I h . . e. IS mo e suggests t at It ts not so much the fetal tissue 1·t If h 
. . . R t u leads to symptoms as tt may be fetal eplthehal mucin as . 
- SOC!ated 
Table 1: Proposed pathophysiological mechanisms of amniotic fluid embolism. 
Embolism ModeJ9 Anaphylactoid Model tO 
Etiology 
- Direct emboli of amniotic/fetal origin - Immune response to fetal particulate 
matter 
Pathophysiological Events Amniotic fluid gains entry into maternal 
circulation 
- Amniotic fluid gains entry into mater-
nal circulation 
- Fluid containing fetal tissue reaches 
pulmonary circulation, results in capil-
lary leak and bronchospasm 
- fetal tissues, in particular fetal epithelia 
mucin-associated glycoproteins trigger 
immune response as well as the release 
of procoagulant factors - Pulmonary congestion leads to a right 
heart failure with drop in cardiac output, 
hypotension 
- va cular occlusion and vasospasms fol-
low, trigger left heart failure and subse-
quent decline in cardiac output - fetal tissue gains access to arterial sys-
tem through shunt or patent foramen, 
promotes coagulopathy 
Outcome - Right heart failure, in addition to all 
other characteristics noted 
- Left heart failure , in addition to all 
other characteristics noted 
glycoproteins (which release procoagulant factors and 
leukotrienes), which trigger vascular occlusion and vasospasm. A 
key difference in this model is that it encourages left heart failure , 
an observation sometimes noted in AFE. 
Table 1 compares the traditional and new AFE models. Some 
experts have suggested that both models may operate simultane-
ously; however, more research into these theories must be con-
ducted before conclusions can be drawn. 
DIAGNOSIS 
Diagnosis of AFE is difficult due to its rarity, acute onset, 
and a lack of means for definitive diagnosis . Until recently, AFE 
could only be diagnosed by examining fetal contents in the vas-
culature during autopsy 1. 
Respiratory distress and cyanosis are the first signs of AFE 
and are believed to develop within one minute of fluid transfer. 
Hypotension and shock develop immediately after, as can symp-
toms of neurological origin such as confusion and seizures. 
Within only a few minutes, reports have estimated that as high as 
80% of patients progress to cardiac arrest, of which 50% do not 
survives. Beyond this point survival rates generally increase with 
the passage of time. Of those who survive, significant uterine 
hemorrhage secondary to coagulopathy is observed with a fre-
quency of approximately 40%1 3. 
Clinical Suspicion 
Generally, AFE develops during labour, though reports of 
occurrence earlier in gestation and post-partum have been 
madeto. Clinical suspicion for AFE centers around dyspnea and 
hypoxia, cor pulmonale, disseminated intravascular coagulation, 
CVS shock, hypotension, neurological compromise, and fetal 
bradycardia?. Table 2 presents a summary of diagnostic criteria 
currently in use by the United States Registry for AFE. 
Table 2: Key criteria for the diagnosis of amniotic fluid 
embolism'. 
I . Acute hypotension with or without ensuing cardiac arrest 
2. Acute dyspnea and cyanosis leading to hypoxia, with or 
without respiratory arrest. 
3. Coagulopathy- diagnosed either by severe hemorrhage with-
out alternative explanation, or laboratory evidence of fibri-
nolysis. 
4. Onset as early as onset of cervical dilatation, and as late as 
30 minutes post-partum. 
Transesophageal echocardiography has recently been investi-
gated as a means to confirm clinical suspicion of AFE. Important 
findings include enlarged right ventricle and aD-shaped left ven-
tricle that contracts normally and appears to be operating under 
reduced volume load. Significant dilation of the main and distal 
pulmonary trunks is also often evident. To support the diagnosis 
of AFE, other cardiac findings that may play a causative role in 
heart failure must be ruled out, including regional wall defects, 
valve rupture, congenital defects, and outflow obstructionto. 
Finally, modest serum tryptase elevation ( < 10 ng/mL) has 
been observed, assisting the diagnosis of AFE and adding evi-
dence to the immune-mediated mechanism for the development 
of AFE symptoms'' · Serum tryptase is released exclusively from 
mast cells and is significantly elevated in fatal anaphylaxis. 
Post-mortem Diagnosis 
Gross findings are relatively non-specific for AFE, and 
include patchy edema, atelectasis, disseminated intravascular 
coagulation, and pulmonary hyperinflation. Presence of fetal tis-
sue matter, including epithelia and hair, in the maternal intravas-
cular space may also be seenll .t2. Immunohistochemistry is of 
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considerable utility in diagnosing cases of APE by detecting par-
ticulates of fetal origin in the pulmonary vasculature. 
Specifically, high and low molecular weight cytokeratins, alcian 
blue PAS at pH 2.5, Attwood, Movat connective tissue, and oil red 
0 stains can detect hallmarks of APE, including fetal squamous 
epithelia, mucin and lipid dropletsii ,I2. Monoclonal antibody 
TKH-2 has been recently shown to detect glycoproteins associat-
ed with APEI 2. 
Differential Diagnosis of Amniotic Fluid Embolism 
The differential diagnosis of APE centers around the circula-
tory, respiratory, coagulation, and neurologic concerns and 
includes: Hypotension/Shock symptoms - Septic shock, 
Hemorrhagic shock, Anaphylactic reaction, Myocardial infarc-
tion, Cardiac arrhythmias; Respiratory distress - Pulmonary 
embolism of other etiology, Pulmonary edema, Complications of 
anesthesia, Aspiration; Bleeding disorders - Disseminated 
intravascular coagulation, Placental abruption, Uterine rupture, 
Uterine atony; Neurological conditions - Eclampsia, Epilepsy, 
Cerebrovascular accident, Hypoglycemia I. 
MANAGEMENT 
Successful management of APE stems from correcting, as 
rapidly as possible, the symptoms noted above. Interventions fall 
broadly under the categories of respiratory, circulation, coagula-
tion, and fetal concerns. 
Respiratory management includes monitoring oxygen satura-
tion, and administering I 00% oxygen through any means. 
Intubation may be considered if a more aggressive approach is 
warranted and could include positive-pressure venti lation starting 
at 5 em H20, increasing at 2 em H20 intervals until reasonable 
Pa02 and Sa02 levels are attained14. 
The most pressing concern regarding circulation is clearly 
the possibility of cardiac arrest, and must be addressed promptly. 
Electrocardiographic observation is useful in monitoring for 
arrhythrnias9. Delivery of the child also reduces uterine pressure 
on the inferior vena cava and should be performed as soon as 
essential respiratory and circulatory activity is ensuredl. Volume 
replacement consisting of an isotonic crystalloid solution should 
be also supplied to maintain a systolic blood pressure of at least 
90 mmHg, with a minimum urine output of 25 mL/h indicating 
adequate organ function1 4. 
Hemorrhage and coagulation are the final barriers to uc-
cessful recovery and must also be controlled quickly to promote 
recovery. Uterine massage may be useful in controlling uterine 
bleeding. If massage and normal pharmacological approaches are 
unsuccessful , a hysterectomy may be necessitatedl. Blood com-
ponent or whole transfusion represents first line therapy for cor-
rection of coagulopathy and should be administered as soon as 
critical respiratory and cardiac events, if present, are under con-
trol. Transfusion is dually-effective in this application as it has 
been shown to be successful in both correcting maternal coagu-
lopathy as well as directly binding fetal particulatesl .s. 
Fetal concerns center primarily around hypoxia and are best 
treated by emergency delivery or cesarean if resuscitation of the 
mother is unsuccessful. 
CONCLUSION 
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Amniotic fluid embolism is a rare and often fatal complic~-
. . . kl cogm· zed on the basts t10n of pregnancy which must be qUJC Y re . 
of clinical signs and symptoms and managed effectively to pro-
h th and child. Current mote a favourable outcome for bot mo er . 
. . t of cardioresprratory therapy centers on mtens1ve managemen ' 
coagulatory and fetal complications. Recent evidence suggests 
that an i~une-mediated response plays a role in AFE's ons~t 
. . h · dt'rected towards this and raptd progressiOn. Current researc IS 
anaphylactoid component. More research needs to be done to 
understand APE- however current theories may soon lead us to 
more effective diagnostic and treatment methods. 
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Health Promotion 
A Review of Current Literature on NuvaRing®, a Contraceptive Vaginal Ring 
Michelle Ngo, B.Sc. B.Ed. , Meds 2007 
The number of choices for daily and non-daily hormonal methods of contraception are increasing. This aUows 
women to choose a contraception method that fits their lifestyle and preferences. The combined oral contra-
ceptive pill is the preferred method of many women and is often used as the standard that new methods are 
measured against. However, methods of contraception that do not require once-daily oral administration and 
ones that avoid daily fluctuations of hormones may improve compliance. Transdermal hormonal patches, 
intra-uterine systems and hormone injections have addressed these preferences of women. One of the newest 
products, NuvaRing, has been shown to be an effective, easy-to-use, tolerable and convenient method for hor-
monal contraception. 
· A novel contraceptive vaginal ring, NuvaR.ing®, offers 
women another choice for effective and reversible protection 
against pregnancy. It is a small, flexible, transparent ring that con-
tinuously releases 120 Jlg etonogestrel and 15 Jlg ethinyl estradi-
ol daily. It is worn for 3 weeks followed by a 1 week ring-free 
period. NuvaR.ing® has an outer diameter of 54 mm with a cross-
section of 4mm. Women are able to insert and remove the ring 
with ease. It offers a higher bioavailability than traditional com-
bined oral contraceptive (COC) products since it does not require 
gastrointestinal metabolism to exert its effects. NuvaR.ing® pro-
vides a constant serum concentration of hormones since it is a 
controlled-release formulation; this differs from COC products. 
The systemic exposure of ethinyl estradiol is 50% less than that 
experienced with COC products that contain 150 mg desogestrel 
and 30mg ethinyl estrodiol. 
EFFICACY 
NuvaRing® has been shown to have a Pearl Index of 0.65 
(95% CI 0.24-1.41 ). 1 The pregnancies reported may have been 
attributed to misuse of the product like extended ring-free peri-
ods. Similarly, another study reported the Pearl Index to be 0.77 
(95% CI 0.37-1.40).2 Again, noncompliance and a misunder-
standing of how to use the ring were noted. In a review of COC 
products, the Pearl Index was found to be 0.04.3 The Pearl Index 
is defined as the number of pregnancies per 100 women-years of 
exposure. 
CYCLE CONTROL 
Women need contraception that minimizes irregular bleeding 
and allows them to experience a withdrawal bleed so that they can 
be reassured they are not pregnant. Extended bleeding or heavy 
bleeding may also affect a contraceptive product's acceptability 
and user compliance. NuvaR.ing® offers excellent cycle control 
compared to COC products. The incidence of irregular bleeding, 
defined as any bleeding while the ring is in place, was found to be 
<5%.4 This was lower than the incidence of COC groups at 5.4-
38.8%.4 As well, withdrawal bleeding, defined as bleeding when 
the ring is not in place, was 98.5% in all cycles.2 
OVARIAN FUNCTION AND CERVIX 
Reversibility of birth control is an important factor for 
women in choosing a method of contraception. A convenient 
method should adequately suppress ovarian function during use 
and allow quick return of ovarian function once the product is dis-
continued. Two studies monitored follicular diameter on vaginal 
ultrasound as a measure of ovarian function while using the ring. 
Maximum follicular diameter was found to be 11 mm during 
treatment with NuvaR.ing®, a value comparable to that obtained 
with COC products.s Furthermore, only three days of consecutive 
NuvaRing® use is required for interference with follicle growth.6 
Ovarian suppression after 3 weeks ofNuvaRing® use and 21 days 
of COC is comparable. 6 The time to ovulation after removal of the 
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ring is approximately 19 days. 7 There was no data to suggest an 
increased risk for cervical abnormalities with use of the 
NuvaRing®. t 
BLOODWORK 
A risk associated with contraceptive hormones is the devel-
opment of venous thromboembolism. The estrogenic component 
is said to be the main cause but the role of the prostegenic com-
ponent is currently under investigation as well. NuvaRing® does 
increase Factor VII levels while COC products decrease it.? There 
were no other differences between the two contraceptive methods 
in any of the other coagulation factors measured .B NuvaRing® 
causes a higher antithrombin and Protein C activity.? However, 
COC products and NuvaRing® are comparable in anticoagulation 
and fibrinolytic activity in general. Lipid profiles are influenced 
by contraceptive hormones. Estrogen has a favourable effect on 
lipid profile while progestin may counteract this effect by virtue 
of its androgenicity. Etonogestrel has less affinity for androgen 
receptors which may decrease its unfavourable effect on lipids. 
NuvaRing® was found to have a minimal effect on lipids with no 
changes in total cholesterol and a decrease in triglycerides .9 
TOLERABILITY 
In comparison to COC products, NuvaRing® has a higher 
incidence of vaginal discomfort, vaginitis and ring-related events 
such as foreign body sensation, coital problems or expulsion 
associated with its use .J The most frequently reported adverse 
events were vaginitis (13.7%), leucorrhea (5.3%), and vaginiti s 
(5%).1 However, there were few estrogen-related symptoms such 
as breast tenderness and nausea. This may be attributable to the 
lower dose of ethinyl estradiol as compared to most COC prod-
ucts .2 Mean body weight increase was found to be 0.43 +/- 3.35kg 
over 13 cycles of treatment. I 
USER ACCEPTABILITY 
The NuvaRing® provides continuous contraception without 
the daily hassle of taking a pill. It is easy to insert and does not 
require the insertion to be performed by a health care profess ion-
al. NuvaRing® costs approximately $25 a month, which i simi lar 
to the contraceptive patch but more expensive than COC prod-
ucts. It is important to note that NuvaRing® cannot be used with 
certain secondary forms of contraception such as the diaphragm. 
It is a non-biodegradable product made of ethylene vinylacetate 
copolymers and magnesi um stearate. Few studies on the toxicity 
of these materials when used in contraceptives have been per-
formed to date but no adverse local or systemic responses have 
been seen over extended periods in vivo.x In a user acceptability 
study, women responded that they were 96% satisfied with the 
ring after 13 cycles of use, and 97% would recommend the ring. II 
94% of partners of women using the ring reported rarely or never 
minding that the ring was being used.l o If desired, the ring can be 
removed for up to 3 hours at a time for sexual intercourse. 
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COME CARE WITH US 
IN CAPE BRETON ... 
FAMILY MEDICINE 
a career challen.ge ... a lifestyle choice 
ENJOY TI-lE CHALLENGE 
The Cape Breton DtStnct Health Authonty requires the 
servtces of a full tune Fam.tly Physician for the Victoria 
County Memorial HospitaL Located in the scenic village of 
Baddcck, Nova Scotia, Victoria County Memorial is a busy 
rural hospital and one of the eight rural , community and 
reg1onal hosp1tals that supports the District's integrated 
health delivery system . The District also consists of the Cape 
Breton Cancer Centre, Rehabilitat ion and Continuing Care 
fnci lities, Addiction Se.rvices and Public Health Services. The 
hospital serves a populatton of approximately 5.500 that 
mcreases annually w1th seasonal vtSits of tourists to Baddeck s.nd 
surrounding areas. Each year, Victoria County Memorial bas 
about 8,000 vtsits to its Emergency Depru1meot. All candidates 
for tlti s position must be certified by the a llege of Frunily 
Physicians of Canada and be eligible for licensure m ova Scoua. 
ENJOY THE LIFESTYLE 
Located in the heart of Baddeck, Cape Breton Island, Vlctoria County Meruonal is nestled 
a long the shores of tile beautiful Bras d 'Or Lak~ . lt is surrowlded by spcctacula.r scenery 
including nature trails, rivers. world~c lass golf courses and ski facilities . Baddec.k: also 
prov ides affordable hous ing, respected schools. and a variety of commun ity !Uld 
recreational facilities. Baddeck also has a ncb cultural identity and is home to the 
Alexander Graham Bell ational Historic Site nnd Museum . 
Pleas~ direct a ppllcnttous, Including C .V. and three references to : 
Or. M . A. Naqvl, Medical Director Dr. C. C bow/Dr. R. Genge 
Cape Onton DbtTicl Henlth Authorlly Ooddeck Fam ily Practice 
1482 George Street, Sydney, NS B1P IP3 65 High Stree~ Baddeck, 
Fax : (902) 567-792 1 ova Scotia BOE I BO 
B-Mai l· naqvim@cbdha.oshealth.ca Phone : (902) 295-3 165 
Website: www.cbdha.nsbealth.ca 
Medicine and the Law 
A New Plan for Plan B 
Daren Lin, Meds 2007 and Andrea Guerin, Meds 2008 
On April 19th, 2005 Health Canada made the Emergency Contraceptive pill, Plan B, to available behind the 
counter without a prescription.' A doctor's visit is no longer required and pharmacists can dispense Plan B 
after assessing the appropriateness of emergency contraception. The pharmacist is also responsible for pro-
viding counseling on the administration and possible contraindications of the medication, and will make 
referrals for future reproductive health counseling.2 
WHAT IS PLAN B? 
According to the World Health Organization, Plan B is the 
gold standard in hormonal emergency contraception.3 Plan B 
contains two doses of 0.75 mg of levonorgesterol to be taken 12 
hours apart. Common side effects include nausea, vomiting, 
dizziness and fatigue.3 The use of Plan B results in a pregnancy 
rate of only 1.1% - a reduction of 89%.3 
While Plan B can be taken up to 72 hours after unprotected 
intercourse or contraception failure , the maximal effectiveness is 
within the first 24 hours after intercourse.4 Therefore increasing 
accessibility to Plan B is instrumental in reducing the time from 
coitus to emergency contraception administration. Over 80 coun-
tries have now approved pharmacists to dispense emergency con-
traceptive products containing progesterone.s 
REGULATORY CHANGES IN CANADA 
To improve the timely access to Plan B, Health Canada 
amended the Food and Drug Regulations to remove Plan B from 
Schedule F, a list of substances intended for human use that 
require a prescription.6 By allowing the sale of Plan B without a 
prescription, the access to the drug is improved.6 This move has 
the potential to greatly increase the drug's effectiveness.6 To 
remove Plan B from Schedule F, Health Canada reviewed three 
decades of studies covering thousands of women and concluded 
that no serious or lasting adverse events were associated with 
emergency contraception.6 Health Canada also examined the evi-
dence from other countries that allowed easier access to emer-
gency contraception. 6 In these countries, excessive use of emer-
gency contraception (more than three times per year) rarely 
occurred.6 This is also supported by a recent study done in British 
Columbia, which has permitted Plan B to be available behind the 
counter since 2000.7 The incidence of women using emergency 
contraceptive greater than three times during the two year study 
was only 2.1 %.7 Health Canada thus concluded Plan B satisfied 
all of the criteria for nonprescription status. 6 
While Health Canada decides the prescription status, it is the 
National Association of Pharmacy Regulatory Authorities 
(NAPRA) that determines whether a drug is placed behind or over 
the counter.6 NAPRA classified Plan B as a Schedule II drug, 
meaning that it will be placed behind the counter. Health Canada 
has supported this policy, noting that pharmacists are well-posi-
tioned to play a major role in providing contraceptive counsel-
ing.6 However, an editorial in the Canadian Medical Association 
Journal questioned the need that any professional consultation for 
emergency contraception, pointing out that the behind the counter 
status of Plan B compromises a woman's privacy, increases cost 
with professional fees, and creates a barrier to access in small 
towns.s 
THE PHARMACIST' S ROLE 
Another barrier related to Plan B 's behind the counter status 
is that pharmacists can refuse to dispense the drug, an issue of 
UWOMJ 74(1) 2005 25 
important consequences in regions with only one drug store.9 The 
conflict between professional obligations and personal moral 
beliefs, although familiar for physicians, is new for pharmacists 
who believe dispensing emergency contraception is equivalent to 
giving abortion.IO 
Currently, the NAPRA Code of Ethics requires that if a med-
ication is in conflict with the pharmacist's personal beliefs, the 
pharmacist must pre-arrange access to an alternate source that 
minimizes inconvenience to the patient.' ' Pharmacists must also 
provide their patients with information that is truthful , accurate 
and understandable so that the patients are able to make informed 
choices about their health care. II 
Some pharmacists groups have called for changes to the 
Code of Ethics that would add a conscience clause to protect 
pharmacists from liability for refusing to perform an act based on 
conscience.2,12 A challenge has also been made to the current 
guidelines on referral , questioning the appropriateness of requir-
ing pharmacists to refer a patient for the same procedure that s/he 
originally objected to in good conscience.I2 Other writers have 
pointed out that a pharmacist 's democratic right to their own 
moral values does not outweigh their fiduciary obligations to 
their patients because they have willingly entered their field .13 
A commentary in the New England Journal of Medicine 
points out that although the pharmacist declines to dispense Plan 
B because he or she believes that the drug ends a life the patient 
may not share the pharmacist's beliefs. If the patient does become 
pregnant as the result of failure to have timely access to Plan B, 
she may then face the question of abortion - a dilemma that 
could have been avoided.l3 
DIFFERENT DEFINITIONS 
At the crux of this controversy is Plan B 's mechanism of 
action. A recent review of the literature concluded that the main 
mechanism of Plan B is interference with ovulation. I4 While it 
may also alter the endometrium by making it unsuitable for 
implantation, 14 a recent study failed to show levonorgestrel alter 
endometrial receptivity. IS Crucially, Plan B will not interfere with 
an already implanted embryo.l6 Since Plan B does not interfere 
with an existing pregnancy and acts prior to implantation, the 
Society of Obstetricians and Gynecologi ts of Canada label Plan 
B as a contraceptive, not as an abortifacient. I? 
Using these definition s, and 200 I figures from Stati tic 
Canada, it has been estimated that emergency contraception has 
the potential to prevent most of the I 06,41 8 abortions (including 
19,936 among teenagers) performed in Canada every year. I o The 
use of behind the counter emergency contraception in British 
Columbia has allowed increased use of emergency contraception, 
and thus perhaps fewe r abortions.B 
However, these definitions are problematic for individuals 
and groups who hold the belief that life begins at fertiliza-
tion .2,9,IO Pharmacists who hold this belief f ind Plan B akin to 
abortion because Plan B can still interfere with the implantation 
of a fertilized embryo_2,9, IO 
In Colombia and Chile, whose laws protect human life at the 
moment of fertilization, emergency contraception like Plan B is 
illegaJ.l 8 Under Canadian law, preventing ferti lization or inhibit-
ing implantation does not compromise the life of a child.I9 
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flicts with dispensing Plan B. 
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Feature Articles 
"Born to be a Burden": 
A dramatic way to educate medical students about the ethics of prenatal 
screening 
Tim Heerema, Kevin Kuo, Patricia Lee, Raymond Lim, Jeff Rader, Hany Wu, Meds 2005 
Since the implementation of a province-wide maternal serum screening (MSS) pilot program by the Ontario 
Ministry of Health in 1993, MSS has quickJy become widely accepted in the management of pregnant women 
in Ontario, as well as across Canada and other developed countries. Unfortunately, the quick evolution of 
MSS into a routine test for pregnant patients has not been accompanied by enough societal debate on the eth-
ical issues surrounding MSS. A review of literature reveals paucity in the discussion of MSS in association 
\vith issues of eugenics, disability rights, abortion, choice, and the rights and responsibilities of the pregnant 
woman to the fetus, her family, and society. Additionally, healthcare providers have been shown to have poor 
knowledge about the sensitivity and specificity ofMSS, and they often fail to provide adequate and non-biased 
counseling and education in the provision of MSS to patients. As such, the lack of debate and education about 
this seemingly routine but controversial test is unsettling. Thus, an innovative way to stimulate discussion 
about MSS and its potential implications to medical students and health professionals is presented. 
In 1993, the Ontario Ministry of Health implemented a pilot 
project known as Maternal Serum Screening (MSS). Using the 
woman's age and three serum markers: a-fetoprotein, human 
chorionic gonadotropin, and unconjugated estriol, MSS estimates 
the ri sk of having a baby with Down syndrome, an open neural 
tube defect (NTD), or Trisomy 18. MSS is a voluntary screening 
exam that was intended to allow women to make informed deci-
sions about their pregnancy. However, studies have shown that 
healthcare providers often fail to indicate its voluntary nature', 
fail to adequately explain the purpose of the test and the meaning 
of the results2, and often underestimate the fa lse-positive rate of 
MSS3. In addition, the healthcare provider's attitude towards 
abortion often affects the provision of thi s test3. Finally, evalua-
tions of the educational material distributed to patients indicate a 
lack of consistent, comprehensive, and unbiased information 
about MSS4. Despite thi s, participation in the MSS program by 
prenatal care providers has been very high in Ontario, with an 
estimated 88% of healthcare providers routinely offering it3. The 
adoption of MSS as a routine test by the medical community has 
blunted societal debate regarding MSS in association with the 
issues of eugenics, di sability rights, abortion, and the rights and 
responsibilities of the pregnant woman to the fetus, her fam ily, 
and society. It is imperative that a forum exist to help stimulate 
these discussions. Medical educators have demonstrated that lit-
eratures and theatre6 are effective in provoking thought and stim-
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ulating discu ion. As such, the theatrical piece entitled Born to 
Be a Burden was written to address these issues. 
Thi play contain four short skits that tackle the subject 
from a chronological perspective. By having the skits span past, 
present , and future, we hope to show the audience the origins of 
the ethical i ue imbedded in MSS and carry them through to the 
pos ible futuri stic consequences. Therefore, the intention and 
rationale of each kit in this play will be discussed. 
The f irst skit involve a discussion about eugenics by some 
of its mo t prominent supporters from various periods in history. 
Most of the dialogues within this skit are unaltered excerpts from 
the original authors. This was intended to provide the audience a 
fl avour of the way these authors thought and how these thoughts 
were influenced by the political , social, and scientific philoso-
phies at the time. 
A particularly charged issue arose in the writing of this skit. 
"Eugenic " is associated with numerous atrocities committed by 
various governments during the 20th century. However, it was 
~rucia l to put forth the idea that MSS is a form of negative eugen-
ICS and that eugenics encompasses more than just atrocities. 
Eugenics includes the aspirations of philosophers and scientists 
and their vision for a better society. Plato and Sir Francis Galton 
led the charge into the subject, with Dr. John M . MacEachran 
concluding. Dr. MacEachran's recounting of the history of eugen-
ics and steri lization in Alberta illustrates that the movement is not 
merely confined to Nazi Germany. 
The next skit focused on how individual beliefs could poten-
tially interfere with the provision of care to a patient. Doctors are 
human. Life experiences and relationships alter patterns of think-
ing, and physicians bear no immunity to individual biases and 
opinions regarding ethically-charged issues. Ethics courses in 
medical school, however, preach that individual biases must be 
left at the door when one enters medicine. Is this "neutrality of 
opinion" a reasonable request to make of physicians? Do doctors 
succeed in providing "unbiased" information? 
Two doctors face a patient in an office setting to provide 
information. The subject matter is MSS and the medical condi-
tions for which it screens. Each physician presents data selected 
from the medical literature in a factually accurate and seemingly 
non-biased fashion. However, when the two physicians simulta-
neously counsel the patient, it becomes obvious to the audience 
that one physician wishes the patient to receive the MSS, while 
the other does not. The following is a short excerpt from the skit 
to illustrate the style of the script: 
Dr. 1: In the un1 ikely event that your baby has a severe form of 
NTD, it would be detected by U/S later in your pregnancy, and in the 
case of a minor lesion both the MSS and U/S are ineffective. 
Dr. 2: The MSS is 90% effective at predicting severe NTDs. Any 
minor defect that is detectable can alter our decision of delivery 
method or the defect could potentially be treated in utero. 
Dr. 1: Any in utero treatments for NTDs are still in the experimen-
tal phase. 
The hope of the authors was that this skit would force audi-
ence members to consider the power of language when presenting 
medical topics for patient consideration. 
The third play in the series explores the potential impact of 
MSS on people currently affected by disease or disability. The 
play introduces us to John Watson, a man who is driven to find a 
cure for the disease that killed his first love, Cecilia. Unable to 
1 find a cure, he turns to eliminating the disease by screening it out. 
However, he begins to question his discovery when he wonders 
what this method implies about Cecilia. 
It is hoped that this play would stimulate the audience to 
think about a few troubling things : What would have happened if 
the test had been available before Cecilia had been born? What is 
John now saying about the value of Cecilia's life and others like 
her by taking this route to "cure" disease? After all , it was Cecilia 
who inspired the research in the first place! How does one bal-
ance out these considerations against the good done by eliminat-
ing such terrible diseases? 
In our fourth skit, set sometime in the future, the audience 
visits the consequences of a slippery slope approach t•) MSS. The 
Canadian Health Minister argues that pre-implantation genetic 
diagnosis (PGD) is a logical extension of MSS. Instead of screen-
ing for genetic diseases in fetuses , PGD allows "screening" of the 
embryo before implantation. Mothers will no longer need to ago-
nize over whether or not to abort a fetus ; the flawed embryo will 
never be implanted. 
As time passes, PGD becomes as widely accepted as MSS is 
today. Subsequent newscasts narrate the potential consequences. 
Loss of genetic diversity leaves children vulnerable to a previ-
ously innocuous disease. Parental expectations of their "perfect" 
children cause a string of teenage suicides. Preference for boys 
over girls leads to an unbalancing of the population. The stark 
contrast between the potential benefits and risks of allowing our 
children to be genetically screened engages the audience to recon-
sider the original acceptance of MSS. 
The intension of weaving together so many short skits was to 
expose the audience to the many complicated ethical issues 
involved in Maternal Serum Screening. Pro-life and pro-choice 
groups clash over the background issue of abortion. Hints of 
eugenics may be present in the underlying suggestion that indi-
viduals with Down Syndrome, neural tube defects, or Trisomy 18 
are less valuable to society. MSS as a "standard of care" suggests 
that individuals have an obligation to screen for such conditions 
because society does not wish to bear the "burden" that such "dis-
abled" lives will inevitably produce. The ongoing search for 
genetic causes of disease, coupled with the technology to screen 
for such diseases in-utero, suggests that the MSS could easily be 
expanded to include other genetic conditions. But who will 
decide which conditions are to be included? 
MSS has been introduced to our society without an appropri-
ate degree of ethical debate, and this lack of discussion is being 
propagated in medical schools. The MSS is often introduced as a 
simple test to offer parents more information about their preg-
nancy. By using drama in medical teaching, the ethical dilemmas 
concerning MSS can be explored more deeply. Not only do the 
authors and actors of such productions learn about the ethical ter-
ritory, but audience members are also educated by the production. 
Drama can provide the audience with concrete examples of the 
potential consequences of MSS, both positive and negative. It 
puts faces to abstract concepts and thus can be used to reach a 
variety of potential listeners. If done effectively, it can captivate 
interest, challenge intellect, and stimulate emotions. Most impor-
tantly, when followed by an appropriate forum, drama leads to 
discussion . 
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Non-Directive Counselling: Rhetoric Or Reality? 
David Silver, Meds 2006 
"Non-directive counseiJing", with its emphasis on respecting a patient's right and ability to make autonomous 
choices, is widely regarded as being central to the practice of genetic counselling, particularly in regards to 
prenatal screening. Through non-directive counselling, health care professionals endeavour to empower their 
patients to make informed and independent decisions, based on the respective context of their own life and 
free from outside coercion. However, some criticisms of the non-directive approach have been raised within 
the medical community. This paper seeks to outline some of these objections and to examine the role of non-
directive counselling in patient care. 
Unquestionably, prenatal genetic screening has created an 
abundance of new and exciting opportunities within the fie ld of 
prenatal care . Armed with our ever-expanding array of genetic 
tools, it has become relatively easy to screen for and identify an 
abundance of different traits and disorders in utero. However, 
what is not always so simple is deciding what exactly to do with 
that information once it is obtained. From a patient perspective, 
genetic screening in general and prenatal screening in particular 
can result in the need to make extremely difficult decisions, and 
the need for assistance from health care providers in deciphering 
the information presented can be profound. 
Understandably, while genetic testing in pregnancy care 
holds immense therapeutic potential , these tests have also been 
accompanied by a considerable amount of controversy becau e of 
potential misuse. Consequently, the medical community has long 
sought to decide how best to employ the tools granted by 
advancements in genetics appropriate ly and responsibly. With 
regards to prenatal genetic screening, ' non-directive counselling' 
has become established as a central component of patient care. 
Shaped by the medical establishment's long-standing belief in a 
patient's right to autonomous choice, ' non-directiveness' dictates 
that a provider 's obligation is to empower their patient to make 
informed and independent decisions, free of coercion. 
However, despite its seemingly widespread acceptance as a 
central tenet of genetic counselling, the true value of non-direc-
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tive counselling has been call ed into question by some. 
Increasingly, members of the medical community have wondered 
openly whether the concept of non-directiveness is more rhetoric 
than reality, while at the same time going so far as to even ques-
tion whether non-directive counselling is ever truly possible. This 
paper intends to examine some of the objections and criticisms 
ra ised with regard to non-directive counselling and to examine 
it role as a fundamentally patient-centred approach. 
NEUTRALITY: IMPOSSIBLE? 
Despite the best efforts of non-directive counselling to assert 
objectivity and neutral ity, both research and anecdotal evidence 
uggests that this is often not the case. This occurs for a vatiety of 
reasons, not least among them being that it is often easier said 
than done for a counsellor to absolutely suppress his or her own 
feelings and/or biases while counselling. Although they might 
make every possible effort to maintain neutrality, many counsel-
lors admit to occasionally fa lling short of thi goal, whether 
through subtly expressed opinions, or even unconsciously 
through more subtle messages conveyed via body language or 
tone of v01ce. 1 ,2 Some studies have further shown that whi le the 
principle of non-directiveness is embraced by professional bod-
ies, at least throughout the Western world, how it is actually 
employed and to what degree can vary markedly from location to 
location.2 
The difficulty ofnon-directiveness has also been attributed to 
the inherent structure of the patient-counsellor encounter. Several 
commentators propose that an apparent conflict of interest exists 
in the attempt to uphold a sincerely non-directive methodology 
while at the same time working towards preventing a given disor-
der. Along those lines, Clarke contends that "an offer of prenatal 
diagnosis implies a recommendation to accept that offer, which in 
turn entails a tacit recommendation to terminate a pregnancy if it 
is found to show any abnormality."3 Upon receiving the poten-
tially traumatic news that their baby is "abnormal", many patients 
simply do not hear anything else, making it difficult - if not 
impossible - for a counsellor to present all options on equal foot-
ing. Other outlets have supported similar views, arguing that 
while the options for medical treatment are typically presented in 
a descriptive manner, patients often understand them in a norma-
tive sense as well. Essentially, the offer of "medical treatment" is 
not simply understood as providing an objective description of 
what is wrong with the patient or their baby and what their 
options are, but also as what should be done to treat their condi-
tion.4 
SPECIAL PATIENT-PROVIDER RELATIONSHIPS 
The special challenges of the relationship between a patient 
and their primary care provider have also been cited as compli-
cating a counsellor's ability to provide truly non-directive coun-
selling. While counselling is often performed by counsellors who 
do not have a past professional relationship with the patient, it is 
very common for patients to consult their family doctor, for 
example, when faced with such difficult decisions. Though the 
previous establishment of trust, rapport, and a good working rela-
tionship may be beneficial in some ways, it may also result in the 
patient becoming more inclined to simply rely on their family 
doctor's advice unquestioningly. Of course, the opposite may be 
x true in certain situations as well-patients may only be able to 
achieve true empowerment once they feel that their doctor is able 
~ to appreciate the wider context of their life. Yet as Evans & Britt 
• point out, "it is logical to hypothesize that the longer the prior 
association of practitioner and patient, the greater the threat to 
patient autonomy".! Whereas the power differential between 
patient and provider is of critical importance to questions of 
patient autonomy, in situations where a level of trust is already 
strongly entrenched, the potential for physician directiveness (and 
thus a betrayal of patient autonomy) is that much greater. 
PROVIDERS' OBJECTIONS 
Regardless of whether non-directiveness is truly attainable or 
not, some members of the medical community have questioned 
whether it is even an appropriate ideal to strive for in all cases. 
Notably, some commentators have argued that occasionally, rec-
ognizing and respecting a patient's autonomy should not be the 
primary goal. Whereas respect for a patient's autonomy requires 
the practitioner to provide information and enable informed 
choice, the principle of beneficence might require the practition-
er to protect the patient from making decisions that may cause 
them distress or harm in the future . If the doctor 's role is consid-
ered to include both the principles of beneficence and respect for 
autonomy, it follows that in certain cases counsellors might be 
justified in abandoning purely non-directive techniques and 
attempting to persuade patients to reconsider thei r decisions for 
the patient 's own benefitS 
Similarly, many counsellors have at times expressed dis-
favour with pure non-directive counselling due to its restrictions 
against insuring that those counselled are fully aware of the moral 
consequences of their decisions. In his exploration of the value of 
non-directiveness in genetic counselling, Clarke questions 
whether the medical profession has "fled so far from medical 
paternalism that we deny ethical responsibility for our profes-
sional activities?" Clarke further expresses resentment at "being 
obliged, as I often feel that I am, to be economical with the truth 
in discussions with families" in certain situations in order to avoid 
adding to feelings of sadness and guilt.3 For Clarke and others, 
non-directiveness can at times amount to merely 'passing the 
buck' by shirking moral and professional responsibilities at a time 
when patients face already incredibly difficult choices and might 
need a counsellor's experience and expertise most. 
NOT SHARED CONCERNS? 
Conversely, it might not be surprising to observe that in many 
cases the principles of non-directive counselling are not valued 
particularly highly by the very people whose rights it seeks to pro-
tect. While the medical profession itself holds up issues such as 
non-directive counselling, privacy, and informed consent as items 
of utmost importance, studies of the public 's opinions regarding 
genetic counselling highlight entirely different concerns. 
Specifically, such studies indicate that while patients do not wish 
to be expressly told what to do, they do expect to be given some 
guidance from their health care providers and not simply infor-
mation and facts alone.6 Additionally, many consumers of genet-
ic services believe that if asked, providers should offer their opin-
ions of what they would do if in the same situation. 
SUMMARY 
As physicians and counsellors, it is important to remain 
aware of the fact that the context of every patient's life is neces-
sarily different from one 's own, and that the ideas and assump-
tions that shape one 's own world view do not necessarily apply to 
someone else 's. It is our responsibility as physician-counsellors to 
recognize and respect that context from which the patient has 
been shaped, to do our best to assist our patients to assess their 
own situations as completely as they can, and finally, to empow-
er them to act accordingly. Granted, it is difficult - maybe even 
unrealistic - to imagine that all obstacles can be overcome in 
order to achieve true neutrality; as stated above, it is rare that a 
practitioner can remove him/herself and his/her opinions so com-
pletely from the decision making process so as to grant patients 
absolute autonomy. As expressed by Evans & Britt, true neutrali-
ty is "an ideal to be striven towards rather than an actuality to be 
achieved". I Clearly, though it remains widely accepted as a cen-
tral pillar of genetic counselling, non-directive counselling is by 
no means free from difficulties and complications. However, to 
admit such a reality should by no means diminish efforts to 
achieve the goals of non-directiveness. 
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The Experience of Infertility For Women From a Psychological and Social 
Perspective 
Shirley Chow, Meds 2006 
For as long as men and women have been procreating there have been those that have experienced infertility. 
Infertility, defined as the inability for a couple to conceive after 12 or more months of regular intercourse 
without contraception, can be a significant life crisis for a couple who is planning to start a family. Because 
this can be extremely devastating for couples of childbearing age, there is an urgent need for health care 
providers to respond to the suffering of infertility patients and to interpret the personal meaning of the expe-
rience from an infertile person's perspective. Not only is infertility a medical and physiological state for the 
individual, it is also a significant psychological state conditioned by social realities. The focus of this paper is 
to promote a greater understanding of how women, desiring children, perceive, react to, and cope with their 
inability to conceive, to the end that health care workers may be able to provide support and guidance to help 
these women. 
Queen Mary of England, daughter of Henry VIII and 
Katherine of Aragon, inherited the throne, with one of her most 
important goals the birth of a child who might succeed her. 
Though she would convince herself she was pregnant, once suf-
fering from a "phantom pregnancy" wherein she gained the req-
uisite weight, stopped menstruating, and suffered with morning 
sickness, she was never able to conceive. ' Indeed her "phantom 
pregnancy" was subsequently attributed to a tumour in her stom-
ach which, combined with the lack of a menstrual cycle and her 
own fervent prayers, made her believe she was pregnant. The 
humiliating and heartbreaking realization that she could not have 
a child is viewed by contemporary historians as the greatest life 
tragedy of Mary "the Barren Queen" of England. 
Queen Mary's anguish surrounding her infertility is not 
unique to her. Many women have had to cope with infertility 
throughout the ages. Although infertility can seem like a very 
individual and personal struggle, it is important for women to 
know that they are not alone. Today, it is estimated that 10% to 
20% of couples will be unable to conceive after one year of 
actively attempting to become pregnant.2 A great need exists for 
health care providers to interpret the personal meaning of the 
experience from an infertile woman's perspective and to respond 
to their suffering compassionately. 
CURRENT EXPERIENCES OF INFERTILITY 
Recent census statistics indicate that a family composed of a 
married man and woman and their child(ren) continues to be a 
norm in American society.s In Canada, the desire to have and 
raise a family has been described as " the most basic and shared 
human dream".6 Many women expect to bear a child, and the 
decision whether or not to have children is described as a con-
scious, ongoing consideration for a woman entering adulthood, 
integrally linked to her developing life plans.4 The norms of soci-
ety portray parenthood as a desirable and/or inevitable part of life, 
and create a social structure in which childless women are consid-
ered an unenviable social anomaly. Despite 30% to 40% of infer-
tility cases being caused by a male factor, studies suggest that 
infertility is a more stressful experience for women than for their 
male partners .2,3 Regardless of whether the infertility is a result of 
a medical problem or some unknown factors, this failure to fulfill 
the parenthood role can be detrimental to a women's personal 
identity and result in a myriad of negative psychological states. 
The state of feeling "powerless" comes from a loss of con-
trol. This feeling extends beyond a woman 's physical body. An 
infertile woman may feel a loss of control with respect to her rela-
tionships with others, to planning for her future and planning her 
family, and to the basic exercise of freedom of choice over her fer-
tility.? As one woman who was unsuccessful with fertility treat-
ments noted: 
"It would be one thing if I had decided I didn 't want children, 
but the fact that I have no control over it, that I've done all 
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the medical interventions, and still have no control. I think 
that s probably the most negative thing-the feeling of help-
lessness."? 
In our society, infertile women become stigmatized because 
they are unable to conceive. In one study of 71 women, nearly all 
of the women were able to provide detailed accounts of negative 
responses to their infertility from close family members or 
friends , as well as from acquaintances and strangers.s These 
women developed negative se lf-perceptions that led them to feel 
alienated and isolated from ociety. In a related study by 
Sandelowski and Jones, women felt "forced to tell and explain" 
their chi ldless state, and to hide their negative feelings in order to 
sustain social relationships (e.g. attend a baby shower for a friend 
or ignore insensitive comments). Infertile women also con-
strained or excluded themselves from interactions with others 
because of their infertility.9 The e women also felt pressured to 
receive inappropriate information or support, such as pitying 
comments and "unscientific advice" like "why don't you relax or 
take a vacation, then you ' II get pregnant". to Societal behavior sur-
rounding parenthood and reactions to infertility contribute to the 
devastating emotional distres experienced by infertile individuals. 
Infertile women who have their hopes of bearing chi ldren 
shattered can also become clinica lly depressed. In a qualitative 
de criptive study of 25 women who were infertile due to medical 
or unknown problems, a prevalent theme were feelings of inade-
quacy.? The pattern of depress ive symptoms associated with 
inferti lity is well documented, and occurs most commonly in a 
cyclical pattern of hope at the possibility of conception and 
despair with the onset of men es.tt Months of this habitual dis-
appointment can eventually lead to chronic depression. Studies 
have shown that infertility depression levels in woman can rival 
those of cancer patients.t 2 It has also been observed that infertile 
women have used coping methods of avoidance to deal with their 
stressors. Avoidance-coping strategies may temporarily serve to 
offset feelings of di stress by helping women ignore the issue, 
especially if they have unsupportive ocial networks. But the e 
strategies can also be maladaptive by inhibiting women from pro-
cessing the meaning of the negative life event. For instance, 
women in the study who employed more avoidance-coping strate-
gies had greater negative emotional fee lings (i.e. , greater depre -
sion, greater overa ll psychological di tress, and lower self-esteem) . 
ROLE OF THE HEALTH CARE PROVIDER 
Given the psychological pain and grief inferti le women expe-
rience and the strained relationships that can occur, health care 
providers need to respond and offer guidance. In addition to pro-
viding factual information on physiological causes and treatments 
of infertility, they can also facilitate a conscious awareness of the 
ideological pressures and the negative self-perceptions that lead 
to feelings of powerlessness and stigma associated with infertili-
ty. With the increased understanding of their stigmatized situation, 
infertile women are empowered to take more control of thei r lives 
by considering alternative li fe choices and other options for par-
enthood, and to better understand how to cope with their situation. 
Health care providers can also acknowledge depression a a 
risk factor associated with unsupportive social interactions, and 
that some level of depress ion is natu ral and appropriate in the 
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mourning process of such a great loss.n 
Infertile women should also be encouraged to take a m?re 
proactive approach rather than coping by avoidance strate~tes. 
These approaches could include information seeking or emo~wn­
al processing activities such as attending support groups and JOUr-
nal writing.t4 . 
A discussion on the psychological and social expenence. of 
infertility of women would not be complete without ex~lonng 
their desire for inferti li ty treatment. The desire to have a chtld and 
the hope that a medical treatment will successfully lead to preg-
nancy can motivate women to continue mfertility treatments 
despite low success rates .? Even with the risk of draining all 
financial resources on medical treatments such as in vitro fertil-
ization (IVF), and the emotional and physical risks associated 
with treatment, many women still seek medical solutions.4 This 
drive to seek treatment at any cost may be due to a societal phi-
losophy that doing ' nothing ' is akin to failure to take responsible 
action, whereas doing 'something ' is viewed as leading to the bet-
terment of a given situation . Therefore many women view the 
treatment risks as a nece sary sacrifice and a by-product of per-
sistence.4 When societal views of risk and responsibility are 
teamed with women' per istence in the pursuit of pregnancy, 
medical treatment may be taken to extremes. Thus, health care 
providers, especially tho e involved with reproductive technolo-
gies, must educate infertile women to foster realistic expectations 
about potential outcomes of treatment options. 
COPING WITH INFERTILITY 
The experience of infertility can ultimately be a transforma-
tional proces from the initial emotional distress to acceptmg and 
coping with the diagno i . Acknowledging the emotional frustra-
tion and despair infertile women experience helps to prevent 
women from inappropriately blaming personal inadequacies for 
infertility for which there i most likely no responsibility or from 
inappropriately equating the inability to bear or carry a child with 
the inability to parenti S With time, meaningful reflection, and 
coun elmg, infertile women may begin to accept the reality of 
being unable to bear children and redirect their focus to seek 
alternative solutions to meaningfully fulfill the role of mother-
hood. A one woman reported: 
"I appreciated being told a definite diagnosis [and progno-
sis} becau e then I realized that pregnancy wasn't important, 
it was the parenting that wa important to me, and we put 
ourselves on an adoption list". 7 
CONCLUSION 
Th~ psychosoci.al experience of infertile women may com-
mo~ly mclud~ .feelmgs of powerlessness, stigmatization from 
society, and chmcal depres ion. Guidance and assistance by com-
petent health care profe sionals optima11y m· a s rt . · 
. uppo tve envi-
ronment can asstst women to interpret their reactions t th d . _ 
· d 1 · o e tag nosts, to ea wtth feelings of inadequacy and to · th · 
, regam etr 
sense of purpose. 
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Perinatal Care for Adult Survivors of Child Sexual Abuse 
Nelvia Van Dorp, B.Sc., Meds 2006 
Child sexual abuse (CSA) has a sordid history of being 
prevalent and underreported, with short and long-term conse-
quences that are variable, complex and poorly understood . 
Nevertheless, there is ample evidence to indicate that awareness, 
sensitivity and collaborative approaches on the part of care 
providers can improve the perinatal experience for women who 
were sexually abused in childhood, minimizing retraumatization 
risks and empowering women with respect to their own bodie . 
The prevalence of child sexual abuse is difficult to deter-
mine. Definition and methodological differences in various stud-
ies and population surveys complicate the calculation, as do the 
confounding factors of underreporting and repressed memory. 
Girls are more frequently victimized than boys, with one in three 
to four women and one in six to eight males reporting sexual 
abuse before age 18.5,9 Estimates range from 12-38% of women, 
and as high as 59% with less restrictive definitions that include 
touching and exhibitionism.5,9, 10,12, 16 Women with a history of 
CSA are at risk of revictimization, with between 15% and 79% 
reporting rape in adulthood.14 Notably, women who experienced 
CSA were found to be between two and eleven times more likely 
to be sexually abused in adulthood than non-abused women. 
Since the early 1980's, there has been a significant increase 
in efforts to document and explain the sequelae of CSA that affect 
women's health throughout the lifespan. There is a wide range of 
documented outcomes, which seem to vary in accordance with 
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the type, duration and timing of the abuse, the perpetrator's rela-
tionship with the child, the age and outcome of disclosure experi-
ence, other traumatic experiences, the amount and type of support 
the chi ld received, and the health of other relationships during the 
child's development.l ,4,13 CSA has been linked with post-trau-
matic stre di order (PTSD) ymptoms that occur consistently, 
or present in situations that mimic the setting or experience of 
previous abuse, or arise a a result of other triggers .2,4,11 CSA is 
also associated with increased treatment in adulthood for other 
psychological symptoms, many of which seem to arise from cop-
ing mechanisms that become maladaptive later in life.1 2 These 
include such symptoms as depression, anxiety, low self-esteem, 
suicidal ge ture and attempts, sleep disturbances, personality 
disorders, dissociative disorders and panic attacks.t2 There is also 
a much higher rate of somatoform disorders and chronic pain 
without organic explanation in CSA survivors.9,15 Interpersonal 
difficulties of many types including general social functioning, 
and particularly couple or spousal interactions including dyspare-
unia and sexual dysfunction, are also more prevalent in CSA sur-
vivors ) 
Pregnancy and perinatal experiences are often fraught with 
difficulty for women who were sexually abused as children. For 
some women, internal examinations, cervical smears, childbirth, 
and even visits to the dentist trigger memories of CSA experi-
ences and may lead to dissociation, vaginismus, PTSD symptoms 
or other difficulties.2,tt There are often parallels to the abuse 
experience because of the anatomy involved and the power dif-
ferential in the relationship, especially if procedures and the rea-
son for doing them are not well understood, if movement is 
restricted, or previously traumatized body parts are involved.2,8,tt 
Postpartum issues such as risk of depression, concerns about their 
ability to protect their own child from abuse and fears about the 
' 
'cycle of abuse' can also be particularly distressing for mothers 
who are CSA survivors. Throughout the childbearing years, there 
are particular concerns that caregivers should consider in their 
interactions with women who were sexually abused as children. 
In order to improve the perinatal care experiences for these 
women, practitioners should consider the following recommenda-
tions from care providers who have extensive experience in work-
ing with women who are CSA survivors: 
AWARENESS OF A WOMAN'S ABUSE HISTORY 
The first issue is that of awareness of a woman's CSA histo-
ry, which is best obtained through sensitive screening. Women 
rarely disclose information about sexual abuse experiences to 
physicians, as indicated in as study of 523 women of whom only 
5% of those with an abuse history had ever told a physician.t2 
From another study of 164 patients, only 6% had been asked 
about sexual abuse (SA), although 68% favoured routine inquiry 
by physicians, and 89% felt that physicians could help with prob-
lems from SA.6 Friedman and colleagues also found that 74% of 
the physicians they surveyed felt that they could help with SA-
related problems, and one third felt that screening should be rou-
tine, yet screening for SA occurred at only 11 % of initial visits 
and 15% of annual visits.6 The abused patients in Friedman's 
study were less likely to volunteer information about their CSA 
history, and were more likely to favour direct questioning by the 
practitioner. Karen Holz asserts that by not asking, the care 
provider gives subtle support to the inaccurate belief that the 
patient may have - that abuse doesn't matter, should not have 
long-term effects, and isn 't worth mentioning.9 Abused women 
consulted in qualitative studies say that screening should occur in 
a private setting with ensured confidentiality, when the woman is 
sitting upright and fully clothed, and be accompanied by reassur-
ance that it is normal for her to have difficulty with aspects of 
clinical care, and that efforts will be made to help her cope with 
necessary procedures and treatments.7,9,17 The majority of abused 
women favour routine screening, and an even greater proportion 
of women endorse routine screening within a safe environment by 
a practitioner with adequate training or experience to respond 
sensitively when a woman discloses an abuse history. 
Simkins' and Holz 's years of experience working with 
women taught them that not all abused women disclose their his-
tory even when directly asked. Many women do not have con-
scious memories of their abuse or choose not to disclose initial-
ly.s,9,18 They suggest that care providers should suspect a CSA 
history in patients with the following behavioural clues - addic-
tions self-destructive tendencies, multiple somatic complaints 
with~ut physical cause, poor self esteem, phobias (particularly of 
blood, needles, pelvic exams, hospitals, medical procedures, 
undressing), sexual dysfunction and inappropriate affect, bound-
ary confusion and anxiety, control issues (including shutting 
down labour progress at a level of pain where she can maintain 
control), unwillingness to trust authority figures, and flashbacks 
or body memories with associated PTSD-type symptoms. Even if 
it is not openly acknowledged, a CSA history may have profound 
implications in a woman's life, many of which will influence her 
interactions with health care providers. 
Building a sensitive, trusting relationship is particularly 
important to the quality of perinatal care experiences for women 
who have been abused. Sensitivity to the wide-ranging and long-
term effects is crucial, as are honesty and clarity in all interac-
tions. Trustworthiness in this setting requires consistency of care 
and character, and accessibility within predetermined boundaries. 
It is important to allow time for questions, to be empathic, and to 
provide positive reinforcement to these women that helps to nor-
malize their experience while acknowledging and addressing 
their particular challenges. 
A WOMAN WITH A HISTORY OF CSA MAY NEED 
MORE EXTENSIVE EDUCATION ABOUT THE PHYSI-
CAL ASPECTS OF PREGNANCY AND CHILDBIRTH 
Women with a history of CSA may need more extensive edu-
cation about the physical aspects of pregnancy and childbirth, as 
well as extra encouragement in self-care during pregnancy, since 
many respond to their abuse by becoming alienated from or 
ambivalent about their bodies.2 A woman 's pregnancy and perina-
tal period is less likely to be traumatic if she is empowered in 
decision making with respect to her body and her care plan.9 
Thus, emphasizing choices and informed consent for all proce-
dures is essentiaJ.8,9 Inviting patients to bring their partner, friend 
or family member to appointments if they would prefer that to an 
office staff witness for procedures may be appreciated. Clear and 
thorough explanations - both before and during all procedures 
helps women to understand what is happening, and less likely to 
feel as though they are being violated while in a defenceless posi-
tion. Practitioners should inquire about and respect the patient 's 
wishes regarding the gender of care provider when making a 
referral, since choosing a female caregiver is one way survivors 
may alleviate their fears .B,t6 Language and word choice can also 
trigger abuse memories , particularly paternalistic directives and 
the use of slang.2o Postnatal issues for CSA survivors may include 
breastfeeding difficulty, interpersonal adjustment issues with 
their partner to new roles in the family, fears about the ' cycle of 
abuse' , and difficulty trusting their male partners with the 
baby.s.tt Parenting classes or groups are often a valuable source 
of information and support for these new families . In some cases, 
particularly if the abuse memories surface for the first time dur-
ing the pregnancy or if the implications pose a danger to the 
woman or the fetus , it would be advisable to suggest a referral to 
a counsellor with expertise in the area of abuse to complement 
medical care. 
While the challenges abound, pregnancy and childbirth can 
also be a very positive and affirming time for CSA survivors, as 
it provides an opportunity to learn more about their bodies, take 
more control over their physical well-being, and experience their 
bodies as capable, strong, and creative. Health care professionals, 
particularly those who interact with women throughout their 
childbearing years, are in a unique position to build trusting rela-
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tionships that empower women with respect to their bodies. Such 
interactions facilitate perinatal experiences which counteract the 
abuse outcomes, instead of perpetuating and amplifying the detri-
mental sequelae of CSA. 
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care. We invite you to explore the possibilities of partnering with our 
22,000 highly-skilled employees and 2,000 physicians. 
Visit our Career Opportunities website at www.fraserhealth.ca 
for a detailed listing of our physician opportunities. Interested 
individuals should submit inquiries and/or CV to: Recruitment 
Services, Fraser Health, E-mail: recruitment@fraserhealth.ca; 
Fax: (604) 575-5140. 
We are ... the right move for a rewarding career! 
~ fraserhealth 
Better health. Best in health care. 
www.fraserhealth.ca 
The Motherisk Program - Now at UWO 
Gideon Koren, MD, FRCPC, !vey Chair in Molecular Toxicology, UWO 
One of the most challenging aspects of drug therapy is the 
situation of pregnant women taking medications or exposed to 
chemicals. Since the thalidomide disaster it has become apparent 
that medications which are safe to the mother may be detrimental 
to the developing baby. Common sense may suggest that women 
who are pregnant should not use medications or be exposed to 
chemicals. Sounds simple, but in fact this situation is very com-
plex in "real life" for the following reasons: 
Half of all pregnancies are unplanned; hence millions of 
women expose their fetuses to medications. 
Often untreated maternal illness may harm both mother and 
unborn child. 
Many women are addicted to recreational chemicals and can-
not discontinue their use. 
Millions of women are occupationally exposed to chemicals. 
To address the need for information and counseling for preg-
nant women, we have established in 1985 the Motherisk Program 
at the Hospital for Sick Children in Toronto. Presently the 
Program counsels up to 200 women and health professionals a 
day from coast to coast, as well as from all parts of the world, 
(www.motherisk.org). Motherisk is one of very few such pro-
grams worldwide and by far the largest. 
In addition to counseling, prospective follow-up of pregnan-
cy outcome has led us to the development of the largest database 
worldwide and to the publication of more than 400 peer reviewed 
scientific papers. In parallel, the 70 team members and students 
of Motherisk systematically review all world experience on drugs 
and chemicals during pregnancy and breastfeeding. 
Lastly, being based in a clinical pharmacology/toxicology 
program, Motherisk operates a l~rge research and clinica~ labora-
tory to study drug exposure dunng pregnancy and lactatiOn. O~r 
laboratory pioneered the measurement of drugs of abuse m 
neonatal hair and meconium (the first neonatal stools) as a long 
term "memory" of the drugs the baby "saw" in utero. 
THE IVEY CHAIR 
In July 2004 Motherisk arrived at UWO, as I joined the 
Faculty of Medicine and Dentistry as the Ivey Chair in Molecular 
Toxicology, sharing responsibilities between Toronto and 
London. Together with Drs. Doreen Matsui, Michael Reider, 
David Freeman, David Knoppert and many others at UWO, we 
are establishing an enlarged network that will invite all Canadian 
researchers interested in developmental toxicology to work 
together. 
This will spell exciting new opportunities to interested stu-
dents at all levels of education at UWO. The lvey Chair has devel-
oped the first UWO course in Medical Toxicology to be offered 
in September 2005 . We are already participating in both under-
graduate and postgraduate training of medical toxicology. This 
Chair, together with the new Ivey Chair in Ecohealth research and 
other members of the UWO research community, will embark on 
an exciting research collaboration in how we poison our environ-
ment and are then being adversely affected by it. This issue is near 
and dear to all of us , but has only been sparsely addressed. 
Human Toxicology, related to medicinal drugs or from envi-
ronmental chemicals, is a field that transcends beyond medical 
sciences. It should include scientists in geography, biology, engi-
neering and social sciences, to mention a few. The lvey Chair will 
facilitate such dialogue, hopefully making UWO a leader in how 
to ensure safer use of medications and a safer environment. 
The contact information for the Ivey Chair is: 
rnrouleau@uwo.ca 
Tel: (519) 661-3128 
Room M242D 
Medical Science Building 
For the Vision and detailed plan of the Ivey Chair please visit 
www.med.uwo .ca/MolecularToxicology/Thelvey-Chair-in-
Molecular-Toxicology. 
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Ocular Manifestations of Pre-eclampsia 
Chetna Tailor, Meds 2004 
Pre-eclampsia is an acute condition of pregnancy character-
ized by hypertension, proteinuria, and non-dependent edema 
(hands and face). The condition progresses to eclampsia when 
these symptoms are accompanied by grand mal seizures. It is for-
tunate that neither of these conditions manifest themselves prior 
to the third trimester of pregnancy, as delivery of the child is the 
only definitive treatment. Approximately I 0% of pre-eclamptic 
women will develop the HELPP syndrome (with or without pro-
gressing to eclampsia), characterized by hemolysis, elevated liver 
enzymes, and low platelets. f.Ithough the cause of pre-eclampsia 
is unknown, it is well accepted that the underlying pathophysio-
logic abnormality resulting in the condition is due to generalized 
arteriolar constriction or vasospasm. This, in turn, induces differ-
ing degrees of capillary damage, resulting in protein extravasa-
tion and hemorrhage. I Almost every organ system can be affect-
ed by this vascular abnormality by sustaining damage via hemor-
rhage and necrosis secondary to arteriolar constriction.2 
The visual system is not exempt from being affected by pre-
eclampsia. The condition has been known to affect the conjuncti-
va, retina, retinal vasculature, choroids, optic nerve, and the visu-
al cortex.2 The most common of these effects manifest as the fol-
lowing symptoms: blurred vision, photopsias (flashing lights), 
scotoma, diplopia and blindness. Examination and investigations 
of women with pre-eclampsia have found that these symptoms 
result from retinal arteriolar abnormalities, serous retinal detach-
ments, ischemic optic neuropathy, and cortical blindness.iii 
Ocular findings associated with the HELPP syndrome include 
bilateral serous retinal detachments with ye llow-white subretinal 
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opacities as well as vitreous hemorrhage) The mechanisms that 
induce these changes, resulting in the above-mentioned visual 
symptoms, have not been fully elucidated as of yet. It has been 
suggested, however, that retinal changes may be due in part to sys-
temic vascular diseases such as diabetes and chronic hypertension 
- comorbidities possessed by many pre-eclamptic or eclamptic 
patients. Hormonal changes as well as breakthrough in cerebral 
autoregulation have also been suggested as possible contributors 
to ocular symptoms in these conditions.4 
RETINAL ABNORMALITIES 
The most common retinal abnormality found in pre-eclamp-
tic patients is focal arteriolar spasm and narrowing which may be 
associated with peripapillary or focal areas of retinal edema.4 
Serous retinal detachment occurs in 1% of pre-eclan1ptic 
patients and 10% of eclamptic patients .4 In a non-preeclamptic 
individual the condition is thought to occur as a result of a defect 
in the retinal pign1ent epithelium. This defect leads to focal leak-
age of fluid from the choriocapillaris which in turn potentiates 
serous det~chment of the sensory retina (figure 1 and 2) .5 In 
patients with severe pre-eclampsia or eclampsia, serous retinal 
detachment has been associated with yellowish, opaque retinal 
pigment epithelium lesions. It has been theorized that these 
lesions result from choroidal ischemia or infarction. Fluorescein 
~ngiography in su.ch patients has supported this theory by reveal-
mg that these retmal pigment epithelium lesions correspond to 
areas of delaye~ ch.oroid~l filling .6 This theory is further support-
e.d by th~ locat10n m ~h1ch most of these retinal pigment epithe-
hum les10ns occur - m the macular and peripapillary regions. 
Previous studies have suggested that the close proximity of the 
macular region to the site at which many watershed zones of short 
posterior ciliary arteries and vortex veins meet renders it highly 
vulnerable to ischemic disorders. 6 
Hormones, coagu lation, and hemodynamic processes are all 
thought to play a part in the pathogenesis of serous retinal detach-
ment.3 Hematologic changes in pre-eclampsia, including hemo-
concentration and increased blood viscosity, lead to slowing of 
choroidal blood flow. As a result of the structure of the chorio-
capillaris, there is a rapid deceleration of flow as arterial blood 
moves into the vast network of the choriocapillaris. Under the cir-
cum tances of the hypercoaguable state associated with pregnan-
cy, there may be a tendency for clots to precipitate in the chorio-
capillaris inducing choroidal ischemia. Angiospasm or occlusion 
of the choroidal arterioles may also occur. Choroidal ischemia 
induces ischemic edema, appearing as yellowish, opaque foci in 
the retinal pigment epithelium and deep retina. Serous retinal 
detachments develop subsequent to abnormal permeability of the 
damaged retinal pigment epithelium.6 
Although opaque retinal pigment epithelium lesions and 
serous retinal detachments are commonly found together, they are 
also found in pre-eclamptic patients independent of one another. 
It has been suggested that Jess severe ischemia may alter retinal 
pigment epithelium permeability, inducing retinal detachment 
without subsequent retinal pigment epithelial edema and opacifi-
cation. However, if there is sufficient ischemia to induce cell 
death, retinal detachment may not follow. 6 
Retinal pigment epithelial lesions and serous retinal detach-
ments have been reported to resolve within three weeks in 
approximately 80% and 98%, respectively, of women with severe 
pre-eclampsia and eclampsia.4 There is minimal or no pigmentary 
changes after the resolution of lesions in most cases, although 
pigmentary mottling, pigment clumping, and changes mimicking 
macular dystrophy have occasionally been observed. It is thought 
that delay in choroidal filling in most patients is of too short a 
duration to induce significant retinal pigment epithelial cell death 
and subsequent scarring.6 
CORTICAL BLINDNESS 
Blindness as a visual symptom of pre-eclampsia or eclamp-
sia has recently been studied in greater detail. Historically, blind-
ness was thought to have resulted from retinal abnormalities 
including edema, vascular changes, and detachment. More 
recently, case reports have emphasized cortical blindness, which 
is characterized by intact pupillary light reflexes and normal oph-
thalmoscopic findings .? Current studies correlating neuroimag-
ing and post-mortem pathological findings have shown that tran-
sient cortical blindness results from petechial hemorrhages and 
focal edema in the occipital cortex. Transient scotomas have also 
been shown to result from these changes in the occipital cortex.? 
Most cases of pre-eclamptic blindness are now attributed to 
changes in the occipital cortex.4 
Until recently, the exact mechanism behind the causation of 
cortical blindness was unknown; however, it was postulated to 
have occurred from either 1) cerebral vasospasm with ischemic 
injury, arteriolar necrosis, and cytotoxic ~dema, or 2} in~reased 
capillary permeability with leakage of flmd and protems mto the 
surrounding tissues resulting in va ogenic edema.s A recent case 
report of a pre-eclamptic woman who had suffered from transient 
blindness reported that the use of single-photon-emission CT 
revealed that the cortical blindness resulted from vasogenic 
edema with selective hyperperfusion of the posterior cerebral cir-
culation.& 
Previous studies have found that the posterior cerebral circu-
lation contains fewer synapses with the sympathetic nervous sys-
tem than does the anterior cerebral circulation, which could make 
the former more susceptible to breakthrough of autoregulation (a 
suggested mechani m of cortical blindness). 
Two possible mechanisms by which cerebral autoregulation 
may be overcome by severe hypertension have been suggested. 
The first is overregulation, in which severe cerebral vasoconstric-
tion leads to the lesions seen. The second theory is of break-
through, which proposes that there is a loss of cerebral vascular 
regulation with resultant dilatation leading to focal vasogenic 
edema. This mechanism is supported by the fact that symptoms 
and neuroimaging findings are concentrated in the region of the 
posterior circulation (which is more susceptible to breakthrough 
of autoregulation).9 
Cortical blindness due to pre-eclampsia or eclampsia is 
almost always a transient phenomenon with reports of blindness 
lasting 4 hours to 8 days.4 
CONCLUSION 
Pre-eclampsia and eclampsia are associated with an increased 
incidence of a number of visual changes, including serous retinal 
detachment and blindness. Most of these changes have no specif-
ic treatment in lieu of inducing labour (most disturbances resolve 
postpartum). During the careful monitoring of such a patient by 
an obstetrician, the patient 's visual activity and fundi should also 
be evaluated. If visual compromise is detected, the patient should 
be referred to an ophtalmologist for further evaluation.2 
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Maternal Hypothyroidism in Pregnancy: The Neurodevelopmental 
Manifestations in the Offspring 
Nata lie Kotowycz, Meds 2005 
Thyroid hormones are critical in regulating growth, development and metabolic rate. They are also implicated 
in embryogenesis, fetal maturation and neurodevelopment. Recent studies have examined the clinical manifes-
tations of a lack of thyroid hormone in pregnancy on infant and childhood neurodevelopment. Thyroid hor-
mone deficiency in pregnancy has been implicated in delayed psychomotor development, altered rates of infor-
mation processing as well as lower IQ in the offspring. This article reviews some of the critical studies that have 
examined the neurocognitive manifestations of a lack of thyroid hormone in pregnancy. It highlights the impor-
tance of carefully monitoring preexisting thyroid conditions when treating pregnant women and also empha-
sizes the significance of thoroughly investigating suspected cases of thyroid dysfunction in pregnant women. 
The thyroid gland is responsible for the production of two 
hormones, triiodothyronine (T3) and thyroxine (T4). These hor-
mones play a pivotal ro le in regulating metabolic rate, growth and 
development. They have also been found to be of chief impor-
tance in embryogenesis as well as in fetal maturation and neu-
rodevelopment.' 
The fetal thyroid gland can be recognized by 7 weeks gesta-
tion and it begins sequestering iodine and synthesizing T4 by 8-
10 weeks. The T 4 however is not secreted until 18 to 20 weeks.' 
In contrast, T3 and TSH production and secretion are noted by 12 
weeks.2 It is because the T4 is not secreted until the 18th to 20th 
week of pregnancy that the fetus relies on the passage of mater-
nal thyroid hormone through the placenta. It is interesting to note 
that human coelomic fl uid has been found to contain maternal T4 
as early as the fourth week of gestation.J Fetal development is 
therefore intricately related to the avai lability and placental pas-
sage of maternal thyroid hormone. 
Although maternal thyroid hormone levels may fluctuate to 
some extent through the course of a pregnancy, the body seeks to 
keep them within a narrow range. Nevertheless, 2.5% of preg-
nancies are associated with mild maternal hypothyroidism, which 
is characterized by an elevated serum TSH.4 Uncontro lled 
hypothyroidism in pregnancy is comparatively rare, but it is asso-
ciated with serious complications including low birth weight, 
preeclampsia as well as an increased risk of spontaneous miscar-
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riage and perinatal mortality. s In view of the fact that fetal devel-
opment is in part dependent on maternal thyroid hormones, 
maternal thyroid deficiency is also manifested by neurological 
and developmental delays during infancy and childhood. It is for 
these reasons that physicians must recognize the significance of 
periodic thyroid hormone screening in pregnant women with a 
positive family history of thyroid disease, goiter, nodules or thy-
roid conditions. The following is a synopsis of various studies that 
have examined the specif ic manifestations of maternal hypothy-
roidjsm in pregnancy on infant and child neurodevelopment. A 
primary focus is placed on the role of thyroid hormones in psy-
chomotor development, information processing, and IQ. 
In 1999, a study conducted by Pop et al. examined 220 chil-
dren at 10 months of age using the Bayley Psychomotor 
Developmental Index. 6 All of the children in the study were born 
fo llowing uncomplicated pregnancies and at 12 and 32 weeks ' 
gestation, the mothers had their ff3 , ff4 and TPO antibody sta-
tus measured. The study found a significant positive correlation 
between the infant's PDI score at 10 months and maternal serum 
ff4 concentration at 12 weeks ' gestation. Appreciably lower 
scores on the Bayley Psychomotor Developmental Index were 
seen in the infants born to mothers who at 10 weeks' gestation 
had ff4 levels below the tenth percentile. Evidently, low maternal 
ff4 levels in early pregnancy may have detrimental effects on the 
infant 's psychomotor development. 
An additional study conducted in 1999 evaluated the effect of 
intrauterine and neonatal thyroid hormone deficiency on infant 
cognitive abilities.7 This study assessed infant attention, learning 
and memory. The infants examined in this study suffered from 
thyroid hormone deficiency for one of the following reasons: 
maternal hypothyroidism, maternal hyperthyroidism with con-
comitant anti-thyroid treatment, low-risk prematurity and con-
genital hypothyroidism. Results indicated that sustained attention 
and learning at 6 months of age did not differ between the study 
group and controls; however, a statistically significant difference 
was seen in the area of general attention and reaction time. The 
study group was less attentive and had longer reaction times; the 
latter signifies an altered rate of information processing in the 
infants exposed to thyroid deficiency. 
A study conducted by Haddow et a!. examined the relation-
ship between maternal thyroid hormone levels in pregnancy and 
subsequent IQ scores in children.s In this study, serum was col-
lected from 25 216 pregnant women and the women were divid-
ed into categories based on their serum TSH levels. Forty-seven 
women with TSH levels above the 99.7th percentile and 15 with 
TSH concentrations between the 98th and 99.6th percentile 
agreed to participate in the study. When the children were 
between the ages of 7 and 9, they were asked to perform 15 tests 
of neuropsychological function and the effects of maternal thy-
roid status in pregnancy on the children 's developmental scores 
were assessed. In particular, the tests examined language, read-
ing, visual-motor performance, attention and intelligence. The 
children of hypothyroid mothers performed worse than controls 
on all 15 tests. Word discrimination and attention problems were 
significantly worse in the study group. More specifically, 37% of 
the children born to hypothyroid mothers versus 19% of controls 
had attention problems. Most notably, IQ scores were found to be 
4 points lower in the study group when compared to controls. On 
this note, 15% of the study group versus 5% of controls had IQ 
scores less than 85. Similarly, 23% of children born to hypothy-
roid mothers had learning difficulties at school; this was double 
the rate seen in the control group. Evidently, hypothyroidism in 
pregnancy is not only associated with problems in psychomotor 
development and alterations in information processing but is also 
coupled with poorer school performance and lower scores on 
intelligence tests . 
The physiological and anatomical bases of the behavioral and 
intellectual deficits associated with maternal hypothyroidism in 
pregnancy are complex. To date, animal studies have shown that 
although rats born to hypothyroid mothers have a normal brain 
weight, they have abnormalities in brain amino acid metabolism 
and in the enzymes of glial and neuronal cells.9 Furthermore, 
these rats have decreased dopamine concentrations in the cere-
bellum pons medulla and cerebral hemispheres; the latter is also 
associ;ted with a reduced serotonin concentration.10 In addition, 
the cerebellar cortex has distorted Purkinjie dendritic trees that 
are characterized by shorter branchlets and areas of missing 
spines. II It is likely that similar pathways and anatomical abnor-
malities account for the neurodevelopmental delays exhibited in 
infants and children born to hypothyroid mothers. A human study 
that examined 13 children born with congenital hypothyroidism, 
for which early treatment was sought, found that at age 8 EEG 
patterns in 5 of the patients were indicative of dysfunction in the 
right parietal and left frontal regions.I2 Taken together, these find-
ings suggest that thyroid hormones play a vital role in the devel-
opment of brain structures and neuro logical pathways, which then 
serve as the foundation for learning, behaviour and intelligence. 
Physicians need to realize that the effects of maternal 
hypothyroidism in pregnancy on infant and child neurodevelop-
ment can be detrimental. In May 2002, the American College of 
Obstetricians and Gynecologists, ACOG, developed a practice 
guideline on thyroid disease and pregnancy. Although the ACOG 
believes it is premature to recommend universal hypothyroidism 
screening in pregnant women, it feels that screening with a TSH 
test is highly warranted in women with a history or symptoms of 
thyroid disease. Similarly, pregnant women with a suspected goi-
ter or thyroid nodules should be further evaluated for thyroid dys-
function .IJ Many patients with a history of hypothyroidism will 
also require increased doses of levothyroxine during pregnancy 
and for this reason, in such patients, TSH levels need to be 
assessed during each trimester. Physicians need to ensure that a 
normal thyrotropin concentration is being maintained and that 
any dose adjustments are being made appropriately.I4 Physicians 
need to be very attentive to conditions of thyroid dysfunction and 
subtle thyroid hormone abnormalities when treating pregnant 
women. It is essential that they be aware of the common nature of 
thyroid disease in women and the detrimental effects that thyroid 
dysfunction can have on the pregnancy itself as well as the sub-
sequent neurodevelopment of the offspring. 
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Fetal Surgery: A Review 
Sandeep K. Aggarwal, Meds 2006 
Fetal surgery is one of the most exciting fields that has emerged in recent decades. Bridging a multitude of 
disciplines including obstetrics, paediatrics, surgery, and radiology, the potential of fetal surgery to correct 
those diseases that once frustrated clinicians and surgeons is incalculable. Fetal surgery is based on the idea 
that diseases and malformations that are too late to treat after birth can be corrected prenatally. Such dis-
eases include diaphragmatic hernia, myelomeningoceles, and hydronephrosis. This article reviews some of the 
important motivations and developments for fetal medicine and surgery as well as briefly outlining and dis-
cussing two operative techniques: FETENDO and open fetal surgery. 
EVOLUTION OF FETAL SURGERY 
The fetus has long been shrouded in mystery, inaccessible to 
the interventions of the physician. It is only because of develop-
ments made in the last few decades of the 20th century that we are 
now able to view and treat the fetus as a patient. Perhaps the most 
important initial development was the introduction of sonogra-
phy, which had the advantage over x-rays as being safer and less 
invasive to the fetus and mother. Ultrasound allows accurate 
imaging of fetal anatomy, which can be measured to determine 
normal and abnormal features . In addition, ultrasound allows live 
imaging so that the sonographer can see the fetus move parts of 
its body or even visualize the beating of the heart. This real-time 
technique is also employed in numerous intrauterine procedures 
such as amniocentesis, needle puncture, and tissue sampling. This 
helped form the basis for prenatal testing to find inherited dis-
eases and malformations which could lead to abortions if the dis-
ease was serious enough or relief if the test was negative. That 
was therefore the crux of the matter: technology had allowed 
' ' physicians to detect many prenatal diseases, but beyond the abil-
ity to administer drugs and hormones to treat diseases like con-
genital hypothyroidism, they remained powerless to treat anatom-
ic defects in utero 1• 
The reason treatment in utero was so important came from the 
work of neonatologists and surgeons who studied the pathophysiol-
ogy of the malformations they saw at birth and followed their 
development back into the womb. These physicians were frustrated 
in the clinics by newborns with devastating malformations they 
could do nothing about. In other words, they felt that whatever 
treatment they could provide was too late to be effective, and they 
needed to intervene earlier to change the course of the disease. 
Human disease models were created in fetal animals and the patho-
physiology and effects of in-utero intervention were studied. In 
addition, obstetricians and sonographers were refining their tech-
niques to detect and study the development of anatomic malforma-
tions using ultrasound. Thus, as these two investigations merged, 
the pathophysiology of human fetal disea es such as hydro-
cephalus, hydronephrosis, diaphragmatic hernia, and nonirnmune 
hydrops were defined, and the field of fetal medicine was born2. 
During the 1980's and 1990's, new technologies, clinical tri-
als, and techniques were developed at a few elite centres that had 
the ability to perform such complicated surgeries. The progression 
of fetal surgery as a safe, effective technique remains slow, and 
there have been many setbacks. However, there were some firsts 
that drove research into the field further. Such milestones includ-
ed the first successful open fetal surgery in 1983, the first suc-
cessful repair of a diaphragmatic hernia in 1989, the development 
of fe_to~copic technology in 1995, and the first myelomeningocele 
repa1r m 1997. Currently, successful fetal interventions have been 
made to correct cystadenomatoid malformations of the lung, sac-
crocygeal teratoma, and neural tube defects3. 
UWOMJ 74(1) 2005 45 
As technologies and techniques advance, the potential to cor-
rect more anomalies will increase, but it must be remembered that 
it is an experimental technique and still has the potential to do the 
fetus a great deal of harm. Furthermore, ethical considerations 
must be addressed, underscoring the necessity for proper guide-
lines to ensure the proper use of such procedures. In any case, the 
formation and growth of such professional societies as the 
International Fetal Medicine and Surgery Society (IFMSS), 
which determine the guidelines for fetal treatment, is evidence 
that fetal surgery now has a firm foundation for future growth2. 
OPERATIVE METHODS 
Fetoscopic Surgery: Fetendo 
A minimally invasive technique, fetoscopic surgery has 
advantages over open fetal surgery which include the prevention 
of preterm labour and altered fetal homeostasis due to the proce-
dure as well as the use of local anesthesia4. Fetoscopic surgery is 
based on endoscopic techniques; in other words, to perform a pro-
cedure normally done with open surgery using a minimal incision 
and hence, less morbidity is likely to occur. Being an endoscopic 
technique, fetoscopy has many of the same considerations, such 
as the imaging modality, the manner of access, the environment, 
and the instruments used. Many of these variables are similar to 
conventional endoscopy save for a few alterations and challenges. 
For instance, fetoscopy has the added advantage of using two 
imaging modalities: the endoscope and ultrasound. Furthermore, 
while most endoscopic techniques use a C02 gas-filled environ-
ment, this is toxic to the fetus and therefore a fluid environment 
is instituted and thus involves a greater adaptation of the endo-
scopic technique. The complications that can arise from this tech-
nique are bleeding from the uterine wall or placenta and rupture 
of membranes and amniotic leakages. 
The process of minimally invasive fetal surgery without hys-
terotomy is called FETENDO and can be employed in a plethora 
of correctional interventions such as the repair of diaphragmatic 
hernias, obstructive uropathies, twin-twin transfusion syndrome, 
myelomeningocele, and cleft lip. FETENDO involves less uterine 
trauma and irritation and thus minimizes the chance of preterm 
labour or severe disruption of fetal homeostasis . As a result of 
decreased chance of preterm labour, the use of tocolytics is also 
decreased as is subsequent maternal hospital stay and complica-
tions due to tocolytics6. 
The procedure involves anesthetization of the mother and 
fetus with halogenated agents to increase uterine relaxation. The 
mother is placed in a modified lithotomy position with her legs 
low enough so three surgeons can work from each side. 
Ultrasound is used to determine whether the procedure can be per-
formed percutaneously or by maternal laparotomy and uterine 
manipulation, depending on the position of fetus and placenta. It 
is also used to find the optimal position to place the trocars. Trocar 
placement and their later removal are crucial steps in the surgery, 
as incorrect insertion and removal can result in uterine bleeding or 
membrane rupture. There are many difficulties associated with 
FETENDO, which include the unfamiliar fluid environn1ent, posi-
tioning of the fetus during repair, and accurate imaging 7. 
Open Fetal Surgery 
There have been over 120 open fetal surgical cases in humans, 
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and the technique can and has been used to correct many P.renatal 
malformations, including those done by FETENDO. As w~th any 
open surgical procedure, open fetal surgery via hysterotomy IS asso-
ciated with an increased risk of preterm labour. In addition, because 
open fetal surgery requires the exposure of the fetus to the ope.n 
environment, hypothermia and disturbances in fetal homeostasis 
may result in increased mortality or morbidity. On the other hand, 
open fetal surgery does not have some of the same lirni~ations. as 
FETENDO, such as the need for special instruments, the difficulties 
with a fluid environment, positioning of the fetus, and irnaging2. 
In general, the procedure involves several steps: hysterotomy, 
fetal exposure, correction, closure, and postoperative care. 
Halogenated anesthetics, indomethacin, and antibiotics are given 
before the surgery. The mother is placed in the supine position 
and cardiac and perfusion monitors are placed. A low transverse 
abdominal incision exposes the uterus and ultrasound is used to 
find the placenta and fetus . The uterus is opened utilizing staples 
to preserve homeostasis and prevent membrane rupture. The fetus 
is continuously bathed in warm saline as it is exposed and 
attached to monitoring devices. Once fetal repair is completed, 
absorbable sutures and fibrin glue are used to close the uterus, 
and warn1 Ringer's solution is used to replace amniotic fluid2. 
DISCUSSION 
The gift that fetal surgery provides for its young patient is & 
life without the consequences of devastating malformations that 
are difficult to treat after they are born. While the procedure is 
still widely experimental , the lessons and complications observed 
from initial open fetal surgeries will eventually be used to pro-
mote less invasive FETENDO procedures to correct a growing 
number of diseases . The transition from open to FETENDO surg-
eries will depend on further interest and experience, more clinical 
trials, and continued technological development. Regardless of 
the method, new diseases can be added to the fetal surgeon 's 
repertoire only after their pathophysiology has been clearly eluci-
dated in animal models , underscoring the necessity for further 
research. Furthermore, while the procedure is an exciting one, 
especially to desperate parents eeking a solution, the guidelines 
introduced by IFMSS must be considered in each case. Continued 
growth of fetal surgery relies upon continued development of 
fetoscopic techniques and study of the pathophysiology of fetal 
malformations, ri k factors, and outcomes. 
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The Next Wave - Medical Education Without Borders 
Sherryn Rambihar, Meds 2005 
The devastating tsunami of December 2004 was a reawaken-
ing of global consciousness. The images of swirling chaos 
impelled us to a tsunami of support worldwide, a global heart 
emerging, bringing nations, communities and people together.! 
Jeffrey Sachs, director of the Earth Institute at Columbia 
University and author of The End of Poverty, speaking about the 
unprecedented global response said "a world divided by ethnic 
and religious disputes suddenly faced its common humanity - and 
common mortality - in a disaster of shocking geographic reach ... 
is now united to aid millions of vulnerable people trying to piece 
their lives back together in the wake of the devastation."2 
By redefining our world, this tsunami has forced us to rethink 
our reach. Caring and humanity does not stop at our doorstep. As 
future physicians caring for humanity, we now have additional 
responsibility for involvement further afield. A tsunami a world 
away crashing into our consciousness means the death of distance 
and an opportunity and responsibility for a more global thinking 
and involvement. 
The previous issue of the UWOMJ featured an editorial on 
the new subdiscipline of Peace Through Health, elucidating the 
unique role which health care workers have in promoting peace 
by pursuing health, given the downward spiral of war and disease, 
positive symbiosis of peace and health, and superordinate goals 
such as altruism and justice which motivate those in our vocation. 
Peace through Health looks at the complex systems contributing 
to peace and conflict such as social, political, economic and legal 
ecosystems, and seeks to find global multi-level interventions for 
global problems. Our earliest Peace through Health initiatives at 
Western inspired the development of UWO's Global Health 
Curriculum, as part of a much larger movement within medicine 
and medical education, towards a better ecosystem or complexity 
science understanding of global health and global concern, as evi-
denced in the global heart emerging after the tsunami. 
Physicians in Canada are challenged by the changing needs 
of a dynamic, pluralistic patient population. Statistics Canada's 
new projections for 2017 show that Toronto's ethnic composition 
will be over 50% visible "minority," and schools and educational 
training programs are talking about the importance of preparing 
their graduates with cultural competency skills to thrive and sur-
vive in this world .3 Harvard Medical School has developed a cul-
tural competency in women's health training program to train fac-
ulty to teach about providing culturally competent care for minor-
ity and underserved women, in collaboration with partner univer-
sities and backed by the US Dept of Health and Human Services . 
International health issues also affect our clinical practice of med-
icine, and medical school, the training ground for future physi-
cians, should provide opportunities to acquire the knowledge, 
skills and attitudes to better understand and manage our patients' 
health. The patient-centred ecosystem model espoused at UWO 
reminds us of the multifactorial and complex dynamic influences 
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on an individual 's experience of health and disease and an inter-
national or global health perspective provides a broader context 
within which all these interactions can take place. 
While as medical students we are taught to seek optimum 
health and quality of life for each patient, in practice our respon-
sibilities extend far beyond the individual. Rudolph Virchow 
noted that "medicine is a social science, and politics nothing but 
medicine on a grand scale"4 and this becomes our reality in prac-
tice. September 11 was a "wake-up call that there was a world out 
there full of poverty, injustice and violence which we couldn 't 
divorce ourselves from ."5 The events beginning Sept, 2003 in a 
rural village in China spiraling to the SARS epidemic around the 
world taught us that we are not immune to events hundreds of 
miles away. Gro Harlem Brundtland, Director General of WHO, 
recently said: "In the past, desperate conditions on another conti-
nent might cynically be written out of one's memory. The process 
of globalization has already made such an option impossible. In 
the modem world, bacteria and viruses travel almost as fast as 
money. With globalization, a single microbial sea washes all of 
humankind. The separation between domestic and international 
health problems is no longer usefuJ."6 
There is now a moral imperative to educate medical students 
about the vast differentials in health between and within coun-
tries. North/South inequities in health spending,7 and gross dis-
parities in the global burden of health and disease are only two of 
the many important issues impacting health that should now 
engage us . The first step towards achieving this is an increased 
awareness through education.8 Other important ways to include 
international health in medical education include reassigning 
global research priorities, fostering a culture of understanding 
and social justice amongst medical students, and promoting inter-
disciplinary approaches to health problems, noting the impact of 
socioeconomic inequality on individual and population health . 
Issues that are international in origin intimately affect the 
Canadian health sector,9 and effective public health approaches 
must be both local and global. 
"Medical schools should provide both theoretical training 
and research opportunities on the health consequences of con-
flict" states the Hague Appelt! for Peace, adopted in 1999 by the 
United Nations. Health Canada 's "Social Accountability - A 
Vision for Canadian Medical Schools" IO and recommendations in 
the Health Care and Globalization chapter of the Romanow 
reportll resonate with the current global discussion within acad-
emic and clinical medicine. Exploration of these issues has his-
torically been relegated to extracurricular medical student activi-
tiesl 2 and the medical literature suggests that in-depth in-class 
teaching is rarel 3. However, medical students worldwide are lead-
ing a transformation to include global issues in the medical cur-
riculum at local , national, and intemationallevels.l4 
Schulich UWO Medical School has made important strides 
in this movement to harness the idealism and instincts inherent to 
young physicians, while improving health worldwide. A student-
driven, interdisciplinary global health curriculum has emerged 
from our first Peace through Health involvement and has devel-
oped and grown in scope and vision over the past three years. 
The Faculty of Medicine and Dentistry began by incorporat-
ing a case study highlighting Human Rights, Human Conflict, 
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Human Health: a Global Approach to Public Health as part of a 
Yr IV Ecosystem Health selective in May, 2002 . Des.igned ?Y 
Ashifa Jiwa (UWO Meds 2002), this case study, the firSt ?f Its 
kind in Canada examined connections between human nghts, 
peace building ~nd health care in case-based, interactive mod-
ules. IS 
To work towards our goal of international health issues span-
ning the medical undergraduate curriculum, we then looked to 
Community Health (formerly Health, Illness and Society), an 
interdisciplinary course that extends over the entire four years of 
the medical curriculum. Elective lectures and panel discussions 
were given on peace-through-health issues to first and second 
year students. Patient-Centred Learning was another route used to 
address international health issues in our medical undergraduate 
curriculum, and students in all four years of medical school work-
ing with committees on Gender, Equity, Diversity, Women's 
Health and Ecosystem Health, discussed cases of the week and 
tried to retain inherent medical aspects while adding extra layers 
of social and political context conducive to self-study and small-
group PCL discussions. Symposia open to interested faculty and 
medical students included guest speakers Dr. Joanna Santa-
Barbara of McMaster School of Medicine and Dept of Peace 
Studies, Dr. Graeme MacQueen of the McMaster Institute for 
Peace Studies, and Dr. Neil Arya, President of the Physicians for 
Global Survival. 
Arising out of the overwhelming interest in international 
health issues and opportunities, the UWO Global Health Interest 
Group strives to coordinate curriculum enhancement with the 
many existing extracurricular international health opportunities 
within and beyond the medical school community. The UWO 
Global Health Interest Group is affiliated with our international 
health counterparts at Canadian medical schools, the Canadian 
Student University Network for Social and International Health 
(SUNSIH) and Physicians for Global Survival Student Network. 
Activities are open to the general medical school community, and 
medical student at large can choose their degree of involvement 
in projects of interest. Activities to date have included a Speaker 
Series featuring workshops and talks on topics such as 
Challenges in International Women s Health, Empowerment in 
International Health Development, Rural Health Issues in the 
Developing World, educational display and film presentations to 
medical tudents on AIDS, Hiroshima, and poverty in India, an 
inter-univer ity collaborative project with WarChild teaching 
London high school students modules on Health. Human Rights 
and Sanctions , and Sexual Violence in Conflict and Genocide and 
training teachers within the Thames Valley school board, an inter-
national health forum for sharing international health clinical 
experiences and exchanges, partnership and fundraising strategies 
with medical outreach groups including MedOutreach India, 
Medical Student Initiatives in China and Med Outreach Tanzania 
organizing a book drive for the Kabul library project and 
fundraising for the IFMSA Cote D'Ivoire Medical Student Relief. 
These are just a few of the many initiatives of the Global Health 
Interest Group, and as interest and participation continues to 
grow, so too does leadership capacity and experience for current 
and future international health experiences within and beyond 
medical school. 
It is exciting to be involved with the UWO Global Health 
~nteres~ Group at a time when International Health is becoming 
mcreasmgly important worldwide. The International Federation 
of Medical Students Association (IFMSA) is comprised of stu-
dents from over 80 countries, and has portfolios addressing 
Refugee and Peace Issues, Reproductive Health and AIDS, Public 
Health, Clinical Exchanges and Medical Education Projects. In 
Sweden at the Karolinska Institute, a full-time five week elective 
has become the most popular elective course in the curriculum, 
taken by over half of the students. The aim is to teach how socioe-
conomic, cultural, and environmental factors determine the health 
of nations and how the global burden of disease and demograph-
ic patterns vary between and within countries. The last 2 weeks of 
the course are given in Tanzania, India, or Cuba, where the stu-
dents are taught by local health professionals, and visit hospitals 
and health centres. In the United States, the US-based 
International Health Medical Education Consortium (IHMEC) 
was founded in 1991 "to foster international medical education 
in .. . curriculum, clinical training, career development, and inter-
national health education policy." The American Medical 
Students Association (AMSA) has developed global health edu-
cation modules, a comprehensive curriculum in integrative medi-
cine started in 1992 at the University of Arizonal6 and there are 
collaborative international medicine programs between Columbia 
University and Ben Gurion University.l7 In the United Kingdom, 
MedAct, an organization of health professionals that researches 
and lobbies on global health issues, has produced a global health 
studies curriculum pack which has been used in several medical 
schools already. International Health and Medical Centres intro-
duce global health to undergraduate students, and a BSc in 
International Health has been created at University College, 
London. IS In the Netherlands, medical faculties of two universi-
ties in Amsterdam have recently begun an elective course entitled 
"Health and issues of war and peace." l9 Closer to home, the 
Association of Canadian Medical Colleges is including a special 
session on Global Health issues at the Annual Meeting in May 
2005, and medical educators have been interested in learning 
about ways to integrate global health issues into medical curricu-
la as seen by presentations of the UWO Global Health initiative at 
the Royal College Annual General Meeting and the upcoming 
May 2005 Ontario Medical Education Network Research 
Symposium. Medical schools may be better able to respond to the 
challenges oftheir global-minded students with increased aware-
ness of these issues. 
The tsunami was a defining event that changed us forever. It 
made us rethink the world, bringing other global isues to our con-
sciousness: the life and death disasters of the poor far away, the 
famines in Darfur, violence and starvation in the Congo, the mud-
slides in British Columbia, flooding and waterborne epidemics in 
Guyana, among many others. While as physicians we seek the 
best health for our patients, we should also strive for the health of 
systems to improve global health and the global state of wellbe-
ing. We are no longer just onlookers from a distance; the tsunami 
changed all that. We are now part of the global heart emerging 
and can all be advocates for change. It has been inspiring to be a 
part of the collective engagement of our medical community here 
at Western, introducing global perspectives, and I look forward to 
the new wave emerging after the tsunami, of global heart and 
medical education without borders. 
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I'~AMINGTON 
DISTRICT 
MEMORIAL HOSPITAL 
Leamington District Memorial Hospital, situated on the beautiful shores of Lake Erie, a short 
drive south of Wmdsor and Detroit bas immediate openings for: 
Family Physicians 
With an Underserviced Area designation, number of Family Physicians are urgently needed. 
We have openings also for Family Doctors with an interest in Emergency Medicine. 
Through the generosity of the community, the construction of a suite of hospital-based offices 
bas been recently completed and is available for Family Physicians who wish to open a new 
Family Practice. 
The Town of Leamington, located in the southernmost part of the mainland of Canada, enjoys 
numerous recreational facilities, easy access to natural areas such as Point Pelee National Park 
and Pelee Island, abundant fresh produce, and excellent schools and churches. A balanced 
Lifestyle in excellent working conditions make this a wonderful area to practice in . 
Please visit our website at: www.leamingtonbospltal.com 
We invite your enquiry to : Dr. R. J. Page MD, C.C.F.P 
Chief of Medical Staff 
194 Talbot Street, West 
Leamington, Ontario. N8H I N9 
e-mail rpage@ldmh.org tel: 1-519-326-2373 ext. 4190 Fax. 1-519-322-5584 
FAMILY MEDICINE 
MCI • Great Place • Great Team • Join us. 
lndjvidual flexibility. 
Freedom from administration. 
Specialists in-house. 
Choice of 27 locations. 
Appointment or walk-in. 
" ... efficient, well organized, great staff ... " 
is how our doctors describe the MCI team. 
Interested~ Please contact us. 
MCI Medical Clinics Inc. 
(~16) 440-4040 ext.433 
mcimed.com www.mcimed.com 
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In the North, you'll get the 
challenge you want in a medical 
career and the opportunity to 
enjoy what the North has to offer 
the adventurous spirit. You'll have 
the chance to learn about your 
patients' lives, their language and 
their culture. 
Our salaries are competitive, and 
all positions include a generous 
benefits package. 
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~~., Health and Social Services 
Interested physicians must be eligible 
to be licensed in the NWT. 
For more information on becoming part 
of our health care team, contact: 
Recruitment Officer 
Toll Free: 1-877-241-9356 
Fax(867)873~634 
Email: hlthss_recruitment@gov.nt.ca 
www.nwtphysicians.ca 
~rewm that Make 
a Difference UW00904 
Think About Practice Opportunities At 
The Pembroke Regional Hospital. 
Now Celebrating The Opening Of Its $46 Million Expansion 
And Offering A Full Range Of Services Including 
CT, Nuclear Medicine, An Expanded ER & ICU, 
A New 19-Bed Acute Mental Health Unit, 
A New 40-Bed Medical Unit, 
Expanded Outpatient Rehabilitation Services And A 
22-Bed Inpatient Rehabilitation Unit. 
Currently Recruiting A Variety Of Physicians 
And Healthcare Professionals. 
Songez aux possibilites de pratiquer votre profession 
a I'Hopital regional de Pembroke. 
Hopital celebre en ce moment l'ouverture de ses locaux eJargis,dont 
le coOt s ' eleve a 46 millions de dollars. 
D offre une gamme complete de services, y compris : Ia 
modensitometrie, Ia medecine nucleaire, un service d'urgence et une 
mite de soins intensifs elargis, une nouvelle unite de soins actifs de 
1te men tale de 19 lits , un nouveau service de medecine generale de 40 
lits, des services accrus de readaptation pour les personnes en 
tsultation externe et un service de readaptation de 22 lits destine aux 
personnes hospitalisees. 
Nous sommes presentemeot a Ia recherche de divers 
professioooels de Ia sante. 
<P~ 
~ Leoding,Lear;,;· ,IJ ... , .. Pembroke Caring 'f-1'¥' 
Regional Hospital 
(613) 732-2811/pr@pemgenhos.org/www. pemregbos.org 
~BOC Canada Ltd 
BOC Gases is the most global of any industrial gases company 1n the indusry. 
We operate in more markets than any other industrial gases company, 
contributing to the manufacture of just about every thing produced by man and 
machine . The gases we supply help to produce m1crochips. plastics and steel, 
freeze food , pump beer, fill light bulbs, test electron m1croscopes. keep rivers 
clean and susta1n life for the cntically ill 
BOC has manufactunng operations 1n about 50 countries and sales 1n many 
others. We have around two million customers World-wide. and we sell them 
products rang1ng from a small welding torch nozzle to the worlds b1ggest 
nitrogen plant 
We serve markets in the automotive. chemicals, petroleum, electroniCS and 
semiconductor fabrication sectors We have customers 1n the food processing , 
metals manufacturing , glass, pharmaceuticals, eng1neering fabrication and pulp 
and paper industries We sell environmental technolog1es. laser gases. and 
safety and industrial safety equipment We have customers including universi-
ties, research and development establishments, public utilit1es and medical 
facilities of all kinds 
To meet their d1verce needs , our engineers des1gn. construct. operate and 
maintain air separation units They design and develop gas applications and gas 
equipment, and formulate gas mixtures for lasers and other speacial purposes. 
They des1gn and install effluent and emission treatment systems and are at the 
forefront of developments in applications for CFC-free refngerants 
BOC Canada Ltd 
5975 Falbourne Street. Un1t 2 
Mississauga, Ontario L5R 3W6 Canada 
Tel· 905-501-1700 
www.bocgases.ca 
growth 
. . 
VISIOn 
lifestyle 
The Peterborough Regional Health Centre (PRHC) is nestled in 
the picturesque Kowortho lakes Region . The Kowo rthos offer a unique 
and d iverse ra nge of natura l wonders, cultural activities, and countless 
destinations to exp lore . W ithin on hour's drive of the GTA , Peterborough 
is a fa mily-oriented community where you con enjoy golfing, booting , 
horseback rid ing , hiking , and cycling . 
Progressing towards our new facil ity wi ll a llow for improved health core 
delivery to the more than 300,000 residents o f the reg ion and w il l fulfi ll our 
regiona l role w ith space for more than 500 beds and expanded services. 
A new facility w ill provide space for expanded services and staff to serve 
the residents of the reg ion and to be a centre of excellence in the delivery 
of comprehensive and accessi ble hea lth core . 
For career opportunities, plea se 
visi t ou r website or apply to : 
Kevin Kirkpatrick, Recruiter 
PETERBOROUGH REGIONAL 
HEALTH CENTRE, One Hospital Drive, 
Peterborough, ON K9J 7C6 
Fax: (705) 876-5015 
e-mail: careers@prhc.on.ca 
enrich 
HEAI,TII 
your practice 
expand 
your horizons 
fE~"''RE 
Located in sceni c Ottawa, Queensway Carleton Hospital is 
a patient and family-centred urban community hospital. 
Providing a broad range of progressive acute care serv ices 
to the people of Ottawa and the Ottawa Valley, cornerstone 
programs include: Emergency, Childbirth , Geriatrics, 
Mental Health , Acute Rehabilitation, 
Medical and Surgical Services. With 
a strong focus on the future, QCH will 
soon be expanding and improving its 
setti ng, as a redesign and expansion 
Queensway Carleton 
Hospital 
of its faci lities are currently underway to meet the needs of 
a fast-growing community. 
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Our journey toward 
renewal of the 
London hospitals 
continues. 
London Hospitals 
Building Together 
What's new ••• 
• The new $42 million G.A. Huot Surgical Centre and 
Diagnostic Imaging Centre at St. Ja;eph's Hospital is under 
construction, with an expected completion date of September 
2005. 
• As a key initiative in the development of a new mental 
health care system, St. Joseph's Regional Mental Health Care 
is creating new community programs to support successful 
home living. 
• At LHSC's Victoria Campus the 10-storey shell of the new 
~SIJOS 
www J,ondonhos.p ita I s.ea 
Children's Hospital ofWestem Ontario and Grace Donnelly 
Women's Health Pavilion was topped off in June 2004. When 
it is completed in 2008 the new tower will house women's 
and children's programs, as well as acute mental health 
programs, laboratory services, and the K.L. Sumner Centre 
for Health Learning. 
• The Lawson Health Research Institute has completed two 
new research facilities: The Victoria Research Laboratories at 
Victoria Campus and the Legacy Pavilion, University Campus. 
Through the dedicated efforts of physicians, staff and leadership, we are able to sustain excellence in patient care, 
research and teaching while we work through this complex, exciting, transformation of London's hospital system. 
Committed to providing the best health care possible 
Faites carriere dans un h6pital cinq etoiles *****! 
Un complexe hospitaller unique et de renommee nattonale, l'hOpltal Montfort est un fotabltssement communautalre 
unlversltalre voue a l'excellence. ll se clcwe d'alllalrs en premiere place de tous tes ftabllssements hospltallers de 
la prov1nce pour la satisfaction de Ia clientele. Montfort se dlstlngue par son caractere francophone tout en 
dessetvant sa clientele dans les deux Lansues offtdelles. 
A l'aube de la plus grande expansion de son histofre, Montfort accueillera un nombre Important de nouveaux 
mededns au cours des prochatnes annees. Vous souhaltez fa tre carriere dans un hOpita\ dnq etolles, a ta fine 
pointe de La technologte 1 Con~ltez regul!erement notre site lntemet pour connaitre les opportunttes, ou 
communfquez avec La direction mecltcale. 
Http:www. hopitalmontfort.com 
Pour soumettre votre candidature, veutllez falre parvenlr votre curriculum vitae c\ La Otrectton medtcale, 713 
chemin Montreal, Ott;~wa (Ont;~rlo) K1 K OT2 courr1el : rh®montfort.on.ca 
JOIGNEZ-VOUS 1 une equtpe dynamfque ayant ~ cceur Les so1ns personnaltWs et empretnts de compassion I 
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Important information 
for women during midlife. 
It's all about estrogen. 
From adolescence a woman's estrogen lewis have a familiar cycle. However, at some 
point they start to fluctuate and decline causing symptoms associated with midlife - hot 
flashes, night sweats and mood swings. 
Estrogen Levels from Puber1y lo Menopause 
What nature takes away, however, it can also replace. 
The natural dietary approach. 
In major hea~h studies of Asian and latin women, midlife is a relative non-event'. 
Their diets are traditionally rich in isoflavones (natural plant estrogens) obtained through 
their consumption of lentils. soy, chick peas and other legumes. 
A clinically proven and proprietary formulation. PromensiiN has a specific 
ratio of all four important dietary isoflavones, extracted from nature's richest source -
Australian red dover. This makes the isoflavone content in one tablet of Promensil similar 
to that of traditional Asian and Latin diets. 
In doctor monitored dinical trials. Promensil was 
very successful. In fact. 90% of the women in some dinical 
trials diose to continue taking It after the trials had ended'. 
Just one daily tablet of Promensil, 
standardized to 40 mg, provides eight times as many isoflavones 
as the typical North American diet, with no side effects or weight gain. 
e!S ..... 
[lll/11 It 1\ o,rtun mtendf:'d 
pour un~:" quatanl <llne nt~ l un•llr 
prom ensW 
The natural way to help 
restore balance during mldlife. 
Visit our website -promensil.com 
or write to: F.G.P.O. Box 81210,Anc.aster. Ontario L9G 4X1 
CLINICAL TRIAL INFORMATION 
For a complete package of published clinical trials 
: ......... ~~~~~ .~~.~~~~~.~~~.~ .~~~.~.~-~.~.~.~ -~.': .~-~~~-~~.~-~~.~-~.~ ......... ; 
-CPS 
Canada's Trusted Choice 
INDICATIONS ARE, 
DOCTORS LOVE IT 
e-CPS 
Instant, Accurate, Up to Date 
Launched in June 04, e-CPS is proving highly popular with physicianS---and 
with good reason. It's the all-new interactive version of the CPS, and it 
provides instant access to all the information needed for informed patient 
care. Its close to 3000 Health-Canada approved product monographs 
are constantly updated and always current. It also offers an array of 
easy-to use tools and resources. To preview e-CPS or subscribe, visit 
online at www.pharmacists.ca. 
www. pharmacists.ca • 1-800-917-9489 
CANADIAN ASSOCIATION DES 
PHARMACISTS PliARMACIENS 
ASSOCIATION DU CANADA 
